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MATERNAL AND FETAL OUTCOME IN PREGNANCIES WITH 
MATERNAL CARDIAC DISEASES - A PROSPECTIVE STUDY 
INTRODUCTION 
  About 1-3 % of pregnancies are complicated by heart disease
1, 2
. 
Heart disease constitutes the major non-obstetric cause of maternal 
deaths. Cardiac diseases in pregnancy are broadly classified into 
congenital and acquired. The acquired group includes rheumatic heart 
disease, cardiomyopathies, ischemic heart disease. Among acquired 
group,   rheumatic heart disease is commonest in developing countries
 
including India
3, 4, 5
. Ischemic heart diseases and cardiomyopathies are 
common in the developed countries. 
In normal pregnancy, there is a raise in stroke volume and cardiac 
output
1, 3
. These changes are further aggravated in heart disease. 
Comorbidities like anemia, urinary tract infections, pre-eclampsia 
increase the burden on the heart and aggravate heart failure. Hence, 
antenatal mothers with heart disease need close monitoring and careful 
follow up.  
2 
 
            With advances in the comprehensive cardiac and obstetric care, 
the pregnant women are having safe motherhood. Many of the studies 
conducted previously were retrospective and in small series. Prospective 
study was done over a period of 10 months among women attending a 
government hospital for safe confinement, termination of pregnancy and 
intensive care. 
  
AIMS  
AND  
OBJECTIVES 
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AIMS AND OBJECTIVES 
1.  To analyse the outcomes of pregnancies- both maternal and fetal 
complicated with maternal cardiac diseases. 
2 To study the various maternal and fetal morbidity parameters in 
pregnancies complicated by heart disease and to find their 
incidence. 
3.  To study the factors contributing to maternal and fetal morbidity 
and mortality in cardiac disease. 
  
REVIEW OF 
LITERATURE 
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REVIEW OF LITERATURE 
The first well-known study on heart diseases in pregnancy was 
conducted by Hamilton and Thompson way back in 1921 to 1938 at the 
Boston Lying in Hospital. In India, first study on heart disease was 
conducted by Misoni from Bombay and Sudhir Bose from Calcutta  
in mid-1950s. In this study the prevalence of heart disease varies from 0.3  
to 3.5 %
7, 8,9,10
. 
 Szekely and Smith conducted a large study among 1000 pregnant 
women who were admitted in general hospital in New Castle between the 
years 1942 to 1971. In this western study, Rheumatic heart disease shows 
a declining trend among heart disease. Mitral stenosis was commonest 
RHD and it is seen in 90% of cases. Pulmonary congestion developed in 
15.4% of the cases and pulmonary edema in 1.6% of pregnant women. 
Maternal mortality was seen in 1.6% of the cases and the most common 
causes being pulmonary edema and heart failure. 
Bitch in 1989 and Mc Faul in 1988 found that among pregnant 
women congenital heart disease occurred in 50% of the cases. In 1988 
Tan and De Sueit found that the incidence of rheumatic heart disease to 
be 12%
11
. Sach et al conducted a study from 1954 to 1985 and reported 
that the incidence of maternal mortality was 0.3 - 5.6 per lakh live births. 
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Agon et al conducted a study from 1968 to 1993and reported that 
maternal mortality rate was 8.5%
13, 14
. 
Mathew Sermer, Sameul C.Siu et al performed a prospective study 
on pregnancy outcomes in women with heart disease, and this was 
published in the Circulation Journal, in the year 2001
30  
which includes 
562 pregnant women in Canada from 13 various hospitals. 13% of 
pregnant women have primary cardiac event out of which 55% occurred 
in the antenatal period. The most common cause of cardiac events was 
pulmonary edema and arrhythmia. Presence of  previous cardiac events 
(like transient ischemic attack, heart failure or history of stroke before 
pregnancy) or arrhythmia, functional NYHA class > II or presence of 
cyanosis, left heart obstruction, and compromised left ventricular systolic 
function (ejection fraction less than 40%) were the predictors of cardiac 
events. In 20% of pregnancies, neonatal events like preterm deliveries 
and SGA are observed. NYHA class > II  at the time of admission, 
obstructive left heart disease in mother, presence of cyanosis, maternal 
smoking, use of anticoagulants, twin gestation are found to be the best 
predictors of the neonatal outcome. Surgical intervention was advised 
preconceptionally in women who are at greater risk for cardiac events, 
provided the risk benefit ratio is favorable and they are in need of 
frequent follow-up. 
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 Congenital heart disease was the common cause of heart disease in 
the west during pregnancy. Advanced maternal age, longevity of women 
with heart disease, presence of cardiovascular risk factors contribute to 
increased incidence of maternal heart disease
52
. 
During 1994 to 1999 Jack M, Siu SC, Colman et al conducted a 
prospective study in 302 pregnant women about the neonatal and cardiac 
complications in three hospitals in Toronto
46
. The women who does not 
smoke, not on anticoagulant and the women in age group 20 to 35 years 
have decreased rate of neonatal complications. Among the women having 
heart disease the occurrence of cardiac complications, miscarriages, 
termination are proportionately higher
46.
. Congenital heart disease was 
observed in 64% of the cases, acquired heart disease in 28 percent and 
8% of the pregnant women had arrhythmias. Before conception, 41% of 
women underwent cardiac corrective procedures. In women with heart 
disease and coexisting obstetric risk factors, there is significant increase 
in adverse neonatal events
46
.  
INDIAN SCENARIO  
 Nina Mahale and Mahesh Koregol  studied about 110 cases of 
heart disease complicating pregnancy between the year 1995 and 2006 in 
a retrospective manner and they found that rheumatic heart disease is the 
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most common type of heart disease in India. Of these, mitral stenosis was 
seen in 44.5% of women and mitral regurgitation was present in 20.9% of 
the women. About 85.45% of the women admitted in the hospital belongs 
to NYHA Class I. 8.18% of women underwent surgical correction for 
cardiac indications in the preconceptional period. 18.18% of pregnant 
women developed cardiac complications. About 3.6% of pregnant women 
expired due to pulmonary edema. Small for gestational age was found in 
46.3%, neonatal deaths occurred in 2.9% of babies and stillbirths 
occurred in 6.8% babies. NICU admission was required in  30.1% of 
babies. From this study, they found that maternal cardiac functional 
classification is the major determinant of maternal and fetal outcome and 
its complications
15
. 
Suman Puri, Aman Bhatia et al conducted a study in North India 
and they enrolled 97 pregnant women with cardiac disease. In this study, 
prevalence of heart disease was found to be 4.3%. Among these, 70.1% 
constitutes RHD. About 9% of pregnant women had congenital heart 
disease. Among RHD 19% of the patients had mitral stenosis and 
cardiomyopathy  was seen in 7% of pregnant women. Maternal deaths 
occurred in 3% and was mainly due to cardiac failure, sepsis and shock. 
Cardiac failure occurred in 6% of pregnant women. Among the perinatal 
complications, pre-term deliveries and low birth weight are common. 
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Stillbirths occurred in 14% of the babies and very low birth weight was 
noted in 21% of the babies
16
.  
 In 2006-07, a study was conducted in Andhra Pradesh, which 
includes 60 pregnant women with heart disease. Maternal mortality was 
slightly higher and it was reported in 6.6% of the cases. Main cause of 
maternal death was found to be acute pulmonary edema. As per this 
study, prevalence of heart disease was 0.43%. About 80% of pregnant 
women had rheumatic heart disease. Instrumental delivery was found in 
26% of the cases and preterm delivery was found in 24% of pregnant 
women
22
.
 
Malhotra et al found that there is increased incidence of forceps 
delivery and preterm birth
 
among the cardiac pregnant women when 
compared to non-cardiac cases
23
.
 
In 2013 to 2014, Nagamani et al conducted a prospective cohort 
study in 60 pregnant women and found that there was 1.2% incidence of 
heart disease in the study group. The ratio of RHD with congenital heart 
disease was 60:40. Intra uterine death was noted in 5% of the cases and 
maternal mortality rate was seen in 5% of cases
17
.  
NYHA functional classification and the ejection fraction at the 
time of admission to the hospital were the major determinants in 
predicting the maternal outcome. 
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 Rashmi Singh and Vidhyadhar B Bangal conducted a 
prospective study in heart disease complicating pregnancy in a tertiary 
care hospital that includes 35 women. In this study heart disease, 
prevalence was found to be 1.3%. About 91% pregnant women in this 
study group belongs to lower socioeconomic status. RHD was seen in 
77% of the cases. Mitral stenosis was the commonest heart lesion seen  
and it is found in 40% of cases. The perinatal death rate was 40 per 1000 
live births
40
. 
 In a tertiary referral, institute in Karnataka a retrospective study 
done on 60 pregnant women who were admitted to the hospital. Incidence 
of heart disease was found to be 0.4%. RHD was  seen in 66.7 % of the 
cases. In 63.3% of the patients maternal complications were seen, most 
common being anemia. Preterm labour was seen in 18.4% of cases. The 
most common cardiac complication was congestive cardiac failure. 
Maternal death rate was seen in 3.3% of cases and perinatal death rate 
was seen in 6.6% of the babies
19
.  
HEMODYNAMIC CHANGES DURING PREGNANCY
 
 Plasma volume increases by 40 to 50%. It begins to increase at 6th 
week, peaks at 30th week and plateaus till term. Red cell mass increases 
by 20 to 30% . This disparity leads to haemodilution and physiological 
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anemia of pregnancy. Cardiac output increases by 50%, it starts 
increasing at 6
th
 week. By 12 weeks, cardiac output is 40% that amounts 
to 75%  of  total rise. Cardiac output peaks around 30 weeks and remains 
constant till term. It increases because of  (i) Increase in stroke volume 
(ii) Increase in heart rate (iii) Decreased systemic vascular resistance by 
30%. Early rise in cardiac output is due to increase in stroke volume as a  
result of reduction in peripheral vascular resistance, later rise in cardiac 
output is due to increase in heart  rate and stroke volume due to increased 
blood volume. Blood pressure decreases ; systolic BP falls by 5 to 
10mmHg and diastolic BP falls by 10 to 15mmHg. Diastolic pressure 
falls more than the systolic pressure.  Midtrimester fall in BP is due to 
opening of placental sinuses that contributes to peripheral resistance 
reduction by making pregnant uterus to act like arteriovenous fistula. 
Heart rate increases by 10 to 20 beats/min. Hematocrit level decreases by 
30% by 30 weeks of gestation. Stroke volume increases by 30% . 
Systemic vascular resistance decreases by 20%. Hence, pregnancy 
invariably increases strain on the heart. So the cardiac status should be 
carefully assessed between 28
th
 and 32
nd
 week to find how the heart will 
behave during labour.  
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Cardiac output increase during labour by 30 to 60%, 15% increase 
in 1
st
 stage of labour and 50% increase in 2
nd
 stage of labour. It further 
increases in the 3
rd
 stage of labour. About 500 to 1000ml of  blood is  
returned to circulation due to contraction of uterus, reduction of pressure 
on IVC . These physiological changes revert to normal 2-3 weeks post-
delivery, sometimes may persist up to 12 weeks. 
Right heart catheterization was performed by Clarke et al on 10 
healthy pregnant primigravida women during 35-38 weeks of pregnancy 
and again at 11-13 weeks after delivery in 1989. Through this study, we 
came to know about hemo dynamic changes during pregnancy. Katz and 
associates in 1978 did echocardiography on pregnant women and also in 
postpartum period. The effects of posture on hemodynamics and cardiac 
output in pregnant mothers were studied in detail by Riccarde Del and 
others. 
Clarke found that increase in pulmonary capillary wedge pressure 
in immediate post-partum period was due to loss in resistance in placental 
circulation that in turn leads to increased venous return. This causes 
pulmonary edema in a decompensated heart. Judicious use of intravenous 
fluids is most important to prevent volume overload. 
12 
 
Parameter Change Magnitude Peak(weeks) 
Oxygen Consumption ↑ 20-60% Term 
Oxygen Delivery ↔↑ 70-1400ml/min Term 
Blood plasma volume ↑↑ 45-50 32 weeks 
Red cells ↑ 25-32 30-32 weeks 
Systemic resistance ↓ -2% 16-24 weeks 
Pulmonary resistance ↓ -34% 34 weeks 
BP ↓ -9% 34 weeks 
Heart rate ↑ 20-30% Term 
Stroke volume ↑ 11-32% Term 
Cardiac output ↑ 30-50% Term 
Uteroplacental flow ↑ >100% Term 
 
 Pregnant women with heart disease will have poor cardiac reserve 
and tolerate the pregnancy poorly. Fetus is also at risk because it requires 
continuous oxygen and nutrients supply from the cardiac mother, who is 
already oxygen deprived. Perinatal mortality may be due to preterm, 
IUGR, low birth weight, intra uterine death. The ECG plays a main role 
in the diagnosis of arrhythmias. There is left axis deviation due to 
mechanical changes in the position of heart. ST segments may show 
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nonspecific ST-T wave abnormalities. Echocardiography used to detect 
structural abnormalities. Two-dimensional doppler echocardiography is 
safe during antenatal period. Left ventricular and right ventricular end 
diastolic dimensions increases during pregnancy.  
 
An illustration of normal heart chambers and valves 
HEART DISEASE IN PREGNANCY 
Major changes occurs in the cardiovascular system during 
pregnancy and even a normal variation may mimic a heart disease. 
Metcalfe et al (1986) and Elkayam & Gillichee N (1990) described the 
signs and symptoms of various heart diseases in pregnancy
26
. Specific 
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symptoms of heart disease are progressive dyspnea, hemoptysis, syncope, 
chest pain. Systolic murmur grade 3/6 or greater, diastolic murmur, 
persistent arrhythmias and split second sound are some of the clinical 
indicators of heart disease during pregnancy.  
CLINICAL NYHA CLASSIFICATION 
In 1928, New York heart association derived a method for 
assessing the functional status of the cardiac patients. This method is used 
in the management of patients with heart disease
50
.
 
NYHA I:  This class includes patients with heart disease but have no 
symptoms of cardiac insufficiency or anginal pain.  
NYHA II:  This includes women who are comfortable at rest, but 
ordinary physical activity causes discomfort in form of fatigue, dyspnea. 
NYHA III:  These women are comfortable at rest but less than ordinary 
activity causes fatigue, palpitation, and dyspnea. 
NYHA IV: Severely compromised-inability to perform any physical 
activity without discomfort. Symptoms of  cardiac insufficiency or angina 
may develop even at rest.  
15 
 
The CARPREG study conducted by siu et al identified following 
predictors of cardiac complication in pregnancy
53
.
   
 
1.  Prior cardiac event like heart failure, arrhythmia, stroke before 
pregnancy or transient ischemic attack. 
2.  Pre pregnancy NYHA class II or above.  
3.  Left ventricular ejection fraction <40%.  
4.  Left heart obstruction-mitral valve area <2cm
2
, peak left outflow 
gradient >30mmHg, aortic valve area less than 1.5 sq.cm. 
Based on the number of above predictors risk of adverse effects in 
present pregnancy is calculated. 
           A point is assigned for each of the predictor that is present and the 
CARPREG risk score
53
 is calculated and the risk for maternal cardiac 
complication is estimated as follows: 
Number of risk factors Risk of adverse events (%) 
0 5 
1 27 
>2 75 
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Predictors of complications in pregnant women with congenital 
heart disease is based on the ZAHARA score
54
. 
1. History of  presence of arrhythmias 1.5 
2. NYHA classification of functional status III or IV 0.75  
3. Presence of left heart obstruction 2.5 
4. Prosthesis and mechanical heart valves 4.25 
5. Systemic atrioventricular valve regurgitation 0.75 
6. Pulmonary atrioventricular valve regurgitation 0.75 
7. Use of cardiac drugs prior to pregnancy 1.5 
8. Presence of cyanotic heart disease 1.0 
 
ZAHARA SCORE 
Risk score Complication rate % 
0 to 0.50 2.9 
0.51 to 1.50 7.5 
1.51 to 2.50 17.5 
2.51 to 3.50 43.1 
Above 3.51 70.0 
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RULE OF 5 
Based on time frame of appearance of diseases , this indicates 
common causes of  maternal  mortality  
5 minutes Pulmonary edema, active rheumatic carditis 
5 hours Cardiac failure 
5 days Bacterial endocarditis 
5 weeks Thromboembolic phenomenon 
5 months Peripartum cardiomyopathy 
 
RISK OF CARDIAC DISEASE IN OFFSPRING 
This depends on presence or absence of cardiac disease in their 
parents. 
Normal parents – 1 % 
Either parents having  CHD – 15 % 
Autosomal dominant trait – 50% 
A standard apical four-chamber view in a 2D echo of a normal heart is 
shown below:  
18 
 
 
Cardiac conditions are categorized according to WHO risk 
classification of cardio vascular disease
28.
  
 WHO risk class I 
Uncomplicated mild : 
1. Pulmonary stenosis 
2. Patent ductus arteriosus 
3. Mitral valve prolapse 
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WHO risk class II 
1. Unoperated  atrial or ventricular septal defect  
2. Corrected TOF 
3. Most arrhythmias. 
WHO  risk class II/III 
1. Mild left ventricular impairment 
2. Hypertrophic cardiomyopathy 
3. Valvular heart disease (Not included in WHO class I or IV) 
4. Repaired coarctation 
WHO  risk class III  
1. Presence of mechanical heart valve 
2. Unrepaired Cyanotic cardiac disease 
3.  Other complex congenital cardiac diseases 
4. Systemic right ventricle 
5. Marfan syndrome with aortic dilatation 40 to 45mm 
20 
 
WHO risk class IV 
1. Pulmonary arterial hypertension 
2. LV dysfunction (severe, EF less than 30%) NYHA class 3 or 4 
3. Native severe coarctation  
4. Severe mitral stenosis, severe symptomatic aortic stenosis 
5. Marfan’s  syndrome with aortic dilatation >45mm 
 In WHO risk class I cardiac follow up is limited to one to two 
visits during pregnancy. Cardiac follow up in every trimester is needed in 
class II. In WHO risk class III cardiac and obstetric follow up is needed 
once in every 2 to 4 weeks since they are at high risk of complications. 
Pregnancy is contra indicated in risk class IV. Termination is required in 
pregnant women with this risk class. 
 Based on the mortality percentage in different types of cardiac   
lesions risk categories are as follows. 
Group I: Mortality risk <1% 
1. ASD 
2. VSD 
21 
 
3. PDA 
4. MS – NYHA Class I and II 
5. Corrected TOF 
Group II: Mortality 5 to 15% 
Group II A 
1. MS – NYHA Class III and IV 
2. AS 
3. Uncorrected TOF 
4. Coarctation of aorta without Valvular involvement 
5. Previous myocardial infarction 
Group II B 
1. MS with atrial fibrillation 
2. Artificial valve 
Group III: 25 to 50% 
1. Pulmonary hypertension – Primary, eisenmenger 
2. Marfan syndrome with aortic involvement 
3. Coarctation of aorta with Valvular involvement 
22 
 
MARFAN SYNDROME 
Autosomal dominant disease with high degree of penetrance.  
Linkage analysis is used to diagnose marfans syndrome. Aortic dilatation 
occurs in progressive manner that leads to aortic valve insufficiency. 
Most dangerous complications are aortic dilatation, dissecting aneurysm 
and this can be a cause of maternal death.  
           Normal aortic root dilatation is 2cm. If  aortic root dilatation 
reaches 4cm then the chance of dissection is more. Preconceptional 
elective surgery is considered when dilatation reaches 5 to 6cm. 
RHEUMATIC HEART DISEASE 
 Among the acquired type of heart disease, rheumatic heart disease 
is the common in developing countries. Mitral stenosis is the predominant 
lesion and constitutes three forth of all cases. Aortic valve is next 
commonly involved, the common type of lesion is aortic stenosis. Lao et 
al reported 7% mortality in aortic stenosis in pregnancy. Mitral and aortic 
regurgitations are well tolerated in pregnant mothers.  
23 
 
 
VALVULAR  HEART  DESEASES 
Mitral stenosis 
Mitral stenosis is the most common Valvular heart disease, most 
commonly caused by rheumatic heart disease. Patients with mild degrees 
of MS are usually asymptomatic whereas moderate to severe degrees are 
poorly tolerated. Symptoms are chest pain, haemoptysis, cough, 
exertional dyspnea. Signs seen are loud S1, diastolic thrill, mid diastolic 
murmur. Left atrial pressure increases those results in pulmonary vascular 
congestion. There is left atrial outflow obstruction leading to left atrial 
enlargement and thrombus formation. Left atrial enlargement leads to 
24 
 
atrial fibrillation that in turn leads to systemic arterial embolus. Due to 
stenosed valve left atrial pressure increases that causes increased pressure 
in the pulmonary circuit there by leading to right ventricular enlargement 
and right heart failure. 
 Maternal mortality is <1% in spite of this complications. When the 
mitral valve area is less than 1cm
2
 and NYHA grade IV complications are 
more severe. Prematurity, IUGR, still birth are the common risk involved 
in the babies born to the mother with mitral stenosis.   
Management include reducing the heart rate and left atrial pressure 
by reducing physical activity and beta blockers are started. Diuretics can 
be started in lowest possible doses to reduce pulmonary and systemic 
congestion. Digoxin is given in case of cardiac failure and anticoagulants 
if the patient develops atrial fibrillation to prevent thromboembolic 
manifestations. Corrective surgery in MS if required should preferably be 
done in preconception period itself. Ideal time to perform surgery in the 
antenatal period is 14 to 18 weeks and percutaneous mitral 
commissurotomy is ideal. Closed commissurotomy is an alternative 
surgery. Indication of surgery in antenatal period includes failure of 
medical treatment, pulmonary edema, and profuse uncontrollable 
haemoptysis.   
25 
 
Mitral regurgitation 
In mitral regurgitation, the incompetent valve causes regurgitation 
causing left atrial enlargement. This causes increased pressure in the 
pulmonary circuit. During pregnancy MR is usually well tolerated. Acute 
MR is caused by rupture of chordae tendineae, papillary muscle 
infarction. Chronic MR is caused by rheumatic fever, mitral valve 
prolapse, defects in collagen synthesis.  Asymptomatic patients do not 
require treatment during pregnancy. Symptomatic left ventricular 
dysfunction with hemodynamic abnormalities is treated with digoxin, 
diuretics and nitrates. Mitral valve replacement if required during 
pregnancy is associated with a high incidence of fetal loss.  
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Aortic stenosis 
With decline in incidence of rheumatic heart disease, aortic 
stenosis is less common. Most common cause of aortic stenosis is 
bicuspid aortic valve. Normal aortic valve area is 3 to 4 cm
2
, if valve area 
is <1 cm
2 
there is severe obstruction to flow and pressure overload on left 
ventricle. Ejection fraction decreases and cardiac output is reduced, the 
underlying hemodynamic problem is fixed cardiac output.    Mild to 
moderate AS is usually well tolerated and severe AS threatens the life of 
pregnant women. Pregnant women with severe AS are managed by bed 
rest, treatment of infections. If the diseases not controlled with medical 
management, valve replacement or valvotomy using cardiopulmonary 
bypass is considered. During labour key to the management is avoidance 
of decreased ventricular preload and to maintain the cardiac output. The 
patient in labour should be kept on wet side in order to maintain a safety 
margin in intravascular volume. 
Pregnant women with congenital AS have increased risk of 
congenital heart disease in the foetus of 4%. Hence these women are 
subjected to fetal echocardiography at 20-22 weeks. Second stage of 
labour should be curtailed in order to minimize the alterations in the 
cardiac output that occur during prolonged labour.  
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Aortic regurgitation 
The causes of aortic regurgitation are rheumatic heart disease, 
endocarditis, and congenital, aortic root dilatation in Marfan syndrome. 
Pregnancy is usually well tolerated due to reduction in vascular resistance 
and increase in heart rate with chronic AR there is where there is left 
ventricular hypertrophy and dilatation. The decreased systemic vascular 
resistance of pregnancy reduces the amount of regurgitant blood. Isolated 
aortic regurgitation may be treated with vasodilators such as hydralazine 
or nifedipine along with salt restriction. AR in Marfan syndrome with 
aortic root dilatation may lead to aortic dissection during pregnancy. 
Prosthetic heart valves 
 Pregnancy with mechanical valve may lead to embolism and 
requires anticoagulant therapy to avoid valve thrombosis, stroke, and 
mortality. Bio prosthetic valve does not require anticoagulants but they 
need to be replaced sooner than mechanical valves as they have shorter 
half-lives. Anticoagulants used are unfractionated heparin, low molecular 
weight and oral anticoagulants. OACs provide more effective 
anticoagulation and lower risk of valve thrombosis. Warfarin when used 
in first trimester causes embryopathy that includes nasal hypoplasia and 
chondrodysplasia punctata. The durability of bio prosthetic valves is 
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around 10 years and has not shown to be less in women who have had 
pregnancies. Valve thrombosis is an emergency, and, therefore, women 
with prosthetic valves require regular anticoagulants. The American 
College of Chest Physicians suggested any one of the below methods of 
anticoagulation therapy in pregnant women with prosthetic mechanical 
valves: 
1. LMWH twice daily throughout pregnancy so as to achieve peak 
anti Xa level in 4 hours of administration. 
2. UFH administered twice daily to achieve the mid interval aPTT 
levels twice that of control or to maintain anti Xa levels between 
0.35 to 0.70 Units per ml. 
3. UFH or LMWH as suggested above until 13 weeks of pregnancy 
and then warfarin is substituted till close to delivery when UFH or 
LMWH is resumed. 
4. In women whom thromboembolism risk is very high and in whom 
the efficacy and safety of use of heparin is doubted, warfarin must 
be given throughout pregnancy and with substitution by LMWH or 
UFH near delivery. In addition 75-100 mg of low dose oral aspirin 
must be given. 
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    Anticoagulants prophylaxis needed to 
(i) Prosthetic valves 
(ii) MS with AF 
(iii) PPHTN 
(iv) Eisenmenger syndrome 
(v) Previous H/O thromboembolism  
(vi) Cardiomyopathy 
CONGENITAL HEART DISEASE 
With advances in cardiac care, vast number of women with 
congenital heart disease survives to adulthood and has safe pregnancy and 
delivery. A western study reports that 80-85% of adults with significant 
heart disease have undergone surgical procedures
29
.
 
Patients with 
unrepaired cyanotic congenital heart disease have very high mortality. 
According to Sawhney in pregnant women with congenital heart disease, 
IUGR is seen in 36% of pregnant women and stillbirth in 14% of the 
cases. Among the congenital heart disease, ASD is commonly 
encountered in adults. 
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Zuber and Sign et al predicted a favorable outcome in TOF in 
women who had good LV function and have underwent surgical 
correction before conception
31, 32
. According to Perloff,
 
pregnancy is well 
tolerated in pulmonary stenosis. Whitmore et al and Shimmi et al reported 
a 5-10% inheritance of heart disease in their off springs. 
SPECIFIC CHDs 
Atrial septal defect is the commonest congenital heart disease and 
it is usually well tolerated during pregnancy. Most common type of ASD 
is ostium secundum. Paradoxical embolism occurs when there is shunt of 
blood from right to left entry of venous thrombus through the septal 
defect in to systemic arterial circulation. In such cases, compression 
stockings and prophylactic heparin may be required in pregnant women.   
Ventricular septal defects usually close spontaneously in 
childhood. Most common type is Para membranous. If the size of the 
defect is more than 1.25 cm
2
 symptoms of pulmonary, hypertension and 
heart failure may develop. If the pulmonary arterial pressure reaches 
systemic levels, Eisenmenger syndrome develops and in such cases, 
pregnancy is not advisable. 
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 In Patent ductus arteriosus, (PDA) functional closure of the ductus 
occurs by vasoconstriction. Women with unrepaired PDA might develop 
pulmonary hypertension and heart failure. The incidence of PDA in the 
offspring is < 1%.  Uncorrected cases of coarctation of aorta will lead to 
aortic rupture, cerebral haemorrhage, IE, hypertensive encephalopathy 
and acute circulatory failure. X-rays, ECHO are used in diagnosis. MRI is 
now the preferred modality for diagnosis. In these patients, pregnancy 
should be constantly supervised. It is necessary to keep the systolic 
pressure at the lowest level and super imposed pre-eclampsia if develops 
should be treated immediately.  
Surgical correction can be undertaken during pregnancy but the 
best time for correction is prior to conception.  In case of corrected 
Coarctation, complications are minimal, hypertension is common in the 
presence of increased Coarctation gradient and it is managed with beta-
blockers. The incidence of congenital heart disease in the offspring is 
reported to be 3-4%. 
 Tetralogy of Fallot (TOF) is the most common cyanotic heart 
disease encountered in pregnancy. The components are (i) VSD (ii) Right 
ventricular hypertrophy (iii) Pulmonary stenosis (iv) Overriding of aorta. 
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In uncorrected TOF, pregnancy increases cyanotic attacks, IUGR, fetal 
demise.  
The magnitude of shunt varies inversely with systemic vascular 
resistance, hence during pregnancy, the shunt increases and cyanosis 
worsens when the peripheral resistance decreases. Hematocrit > 60%, 
Spo2 <80% and syncope are the poor prognostic factors.  
          Pregnant women with complex congenital heart diseases like 
tricuspid atresia, transposition of great vessels, single ventricle are now 
well managed during pregnancy and delivery since they are corrected 
with surgical procedures like Mustard, Senning, or Fontan procedures. 
Complications during pregnancy include heart failure, maternal 
arrhythmia, and myocardial infarction.  
   
 
 
 
 
An illustration on the components of TOF. (Tetralogy of Fallot) 
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OTHER HEART DISEASES 
PULMONARY HYPERTENSION 
Pulmonary hypertension is a hemodynamic observation and it is 
defined in non-pregnant individuals when the mean pulmonary pressure 
>25mmHg. WHO classifies causes of pulmonary hypertension in to  
5 categories.  
I .  Pulmonary arterial hypertension 
1. Idiopathic 
2. Familial 
3. Associated with collagen vascular disease, thyrotoxicosis, APLA 
4. Persistent PHTN of new born 
5. Others 
II.  PHTN with  left side heart disease  
1. Leftsided atrial or ventricular disease 
2. Leftsided valvular disease  
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III.  PHTN associated with lung disease 
1. Chronic obstetric pulmonary disease 
2. Interstitial lung disease 
3. Others 
IV.  PHTN due to chronic thromboembolic disease 
V.  Miscellaneous 
Of these Group I diseases specifically affects pulmonary arterioles. 
Plexogenic arteriopathy associated with cirrhosis and portal hypertension 
can also lead to maternal death. These women are at greater risk during 
labour due to decreased venous return.  
Group II disorders are commonly seen in pregnancy. Group III,  IV 
and V are seen in healthy young women. 
They present with vague symptoms, exertional dyspnea is most 
common. Xray chest shows enlarged pulmonary hilar arteries and 
peripheral markings are attenuated. 
In cases with idiopathic pulmonary hypertension maternal 
mortality rate is high up to 30%. 
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In Group I disease pregnancy is strictly contraindicated. 
In Group II carries better prognosis than group I. Women with mild 
to moderate PHTN usually tolerate pregnancy well. Patient advised bed 
rest, given diuretics, nasal oxygen, vasodilators, epoprostenol and 
treprostinil are prostacyclin analogues that can be administered 
parentarlly, inhaled form available as iloprost.   
MITRAL VALVE PROLAPSE   
           MVP is reported in 1.2% of pregnant women and it is due to 
myxomatous degeneration of Valvular leaflet, chordae tendineae, and 
papillary muscle infarction. Also known by other names such as systolic 
click murmur syndrome, barlow syndrome, and redundant cusp 
syndrome. MVP is usually well tolerated during pregnancy but some 
pregnant women may develop mitral regurgitation or arrhythmias. 
Symptomatic pregnant women are given beta blockers there by 
decreasing the sympathetic tone that relieves chest pain and palpitation.  
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SURGICAL CORRECTION 
According to Morris and Menarke, about 75% of children who 
underwent surgical correction for their heart disease remain 
asymptomatic and enter reproductive age
34
. Valve replacements are 
performed nowadays and these women are put on lifelong anticoagulant 
therapy
33
. Heparin is used in the period organogenesis in order to avoid 
teratogenic effects of warfarin
34
.
 
Chan reported that in pregnant women 
with valve replacement mortality rate is 2.9%. 
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ATRIOVENTRICULAR BLOCK 
TYPES 
1. First degree AV block 
2. Second degree AV block 
          i. Mobitz type I 
          ii. Mobitz type II 
3. Third degree AV block 
FIRST DEGREE AV BLOCK: 
PR interval is prolonged to more than 0.20 seconds. This indicates 
delay in conduction of sinus impulse from atria to ventricles, with most 
delay occurring in AV node. Eventhough PR interval is prolonged all  
P waves are conducted. 
CAUSES: 
i. Enhanced vagal tone. 
ii. Drugs like digitalis, beta blockers, calcium channel blockers. 
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TREATMENT: 
First degree AV block is usually benign does not require any 
treatment. Prognosis is usually good. If associated with structural heart 
disease it may progress to higher heart block. 
Our study includes one case of type 1 AV block. she was 
diagnosed during her second pregnancy. Elective repeat LSCS was done 
and her intraoperative and postoperative period were uneventful. 
CARDIAC SURGERY DURING PREGNANCY 
Critical mitral stenosis if diagnosed during pregnancy requires 
surgical treatment. Closed mitral valvotomy was performed previously. In 
recent days percutaneous transcatheter balloon dilatation of mitral valve 
is commonly performed. Mitral valve surgery during pregnancy is 
considered when pulmonary artery pressure more than 50mmHg and in 
patients with NYHA class III/IV. Open heart surgery should be 
performed when the above procedures fails. Cardiac surgeries during 
pregnancy are commonly performed after 20 weeks and it is associated 
with fetal risk including IUGR, preterm birth and fetal demise
38
. 
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According to Arnoni RT and others functional NYHA class 
improved in 91% of cases after cardiac surgery during pregnancy.70% 
were restored to sinus rhythm
37
. The most prevalent heart disease is 
Mitral valve disease.
 
PERIPARTUM CARDIOMYOPATHY PPCM 
PPCM is a type of dilated cardiomyopathy; incidence varies 
between 1:300 to 1:400. National heart, lung, blood institute and office of 
rare diseases establish the below diagnostic criteria for PPCM
35, 36
. 
1. Cardiac failure development in last month of pregnancy or within  
5 months of delivery.  
2. Absence of identifiable cause of cardiac failure. 
3. Absence of recognizable heart disease prior to last month of 
pregnancy. 
4. Left ventricular systolic dysfunction demonstrated by ECHO-
diminished ejection fraction or fractional shortening with dilated 
left ventricle. 
Maternal mortality is decreased in recent years and is about 2 to 3%. 
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MANAGEMENT OF WOMEN WITH CARDIAC DISEASE 
DURING  LABOUR 
First stage 
Detailed history and examination are done. Type of heart disease is 
confirmed and cardiac drugs are reviewed . Admission non stress test for 
fetal well  being is done. Prevaginal examination  is done to asses bishop 
score , pelvic adequacy.  spontaneous onset of labour is awaited unless 
otherwise indicated. 
Analgesia 
This helps in reduction in tachycardia and cardiac output. Epidural 
is given in most cases except in cyanotic cardiac disease, severe AS and 
in women on anticoagulants.  
Women is placed under propped up position , lithotomy position is 
avoided since it causes increase in venous return and increases cardiac 
output. Vitals monitoring done every 15 minutes. Chest auscultation done 
intermittently every 30 minutes. Input output monitoring done. 
Continuous electronic fetal monitoring done. Artificial rupture of 
membranes is avoided since it may cause infection. 
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Second stage 
Patient is kept in left lateral position , nasal O2 administered , 
vitals monitoring is done every 10 minutes. Fluid overload should be 
avoided. Instrumental delivery can be performed to cut short second stage 
of labour. 
Third stage 
Active management of third stage of labour should be done. 
Ergometrine is contraindicated because it causes increased cardiac load 
by pushing additional blood in to circulation. Cardiac drugs to be 
continued. 
CONTRACEPTION IN HEART PATIENTS 
Contraception is by far most important in cardiac patients, 
vasectomy being the safest. Barrier methods like condoms, diaphragms 
are safe but the failure rates are high. Oral contraceptive pills are avoided 
due to risk of thromboembolism, hypertension, and abnormal lipid 
profile. IUCD is very effective and safe and it is inserted under IE 
prophylaxis. In women who have completed their family permanent 
sterilization provided, they are hemodynamically stable. In our setup 
PPIUCD, insertion is done with IE prophylaxis.  
MATERIALS  
AND  
METHODS 
  
42 
 
MATERIALS AND METHODS 
 This prospective study on maternal and fetal outcome in 
pregnancies with maternal cardiac diseases was done in the Department 
of Obstetrics and Gynaecology, Govt. RSRM Hospital, Stanley Medical 
College, Chennai. This is a government referral centre for all the 
surrounding hospitals. The study was conducted over the period of 10 
months from January 2017 to September 2017. 
 All pregnant women diagnosed to have heart disease and admitted 
to the hospital for either safe confinement or terminations of pregnancy, 
any cardiac complications were included in the study. Pregnant women 
with heart disease and labour pain admitted through casualty are also 
included.  
INCLUSION CRITERIA 
1. All patients with heart disease complicating pregnancy irrespective 
of gestational age – without any other medical illness. 
2. Pregnant women diagnosed to have cardiac disease during hospital 
stay. 
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EXCLUSION CRITERIA 
1. Pregnant patients with associated medical illness like anemia, PIH, 
chronic kidney disease, GDM are excluded from the study. 
2. Those who did not give consent for the study.  
Pregnant women with cardiac disease in NYHA class I and II are 
admitted at 36 weeks of gestation. NYHA class III and IV are admitted to 
hospital at once the diagnosis is made. Cardiac symptoms if arise at any 
period of gestation are admitted immediately and intensive care is given 
to such patients. Conditions precipitating heart failure like anemia, 
infections, preeclampsia should be treated promptly. Drugs taken by 
cardiac patients should be revised and cardiology opinion to be obtained. 
Penicillin prophylaxis is given in RHD. Infective endocarditis 
prophylaxis-Inj. Ampicillin (50mg/kg) and Inj. Gentamycin (3mg/kg). 
Caesarean delivery is done for obstetric indications few cardiac 
indications for LSCS are pulmonary hypertension, Eisenmenger 
syndrome, Coarctation of aorta. During labour patient is kept in bed in 
propped up position, nasal oxygen administered. IE prophylaxis if needed 
is administered. Strict monitoring of vital signs, restriction of IV fluids, 
cardiac drugs to be continued in intrapartum period when needed. Second 
stage of labour is curtailed by applying outlet forceps with liberal 
episiotomy. Episiotomy wound is sutured in layers. In the postpartum 
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period patient is monitored for PPH, pulmonary edema, LRI and special 
precautions are taken to prevent these complications. Cardiologist review 
should also be obtained in postpartum period. Breast feeding was started 
as early as possible. Babies were examined by pediatrician. All newborn 
babies are immunized as per national schedule.  
OBSTETRIC OUTCOME  
Obstetric complications observed in mother are missed abortion, 
incomplete abortion, preterm labour, one maternal death due to atrial 
fibrillation with embolic manifestation. Otherwise, women are delivered 
by natural labour, Lscs or by assisted vaginal delivery.   
CARDIAC OUTCOME 
Cardiac complications observed were pulmonary edema, intra op 
fall in saturation, sudden worsening of NYHA grade or sudden cardiac 
arrest and cardiac death. 
NEONATAL OUTCOME 
Neonatal outcomes observed were low birth weight, preterm birth, 
small for gestation, IUGR, large for gestation, baby with single umbilical 
artery, respiratory distress syndrome.  These babies require admission to 
NICU.   
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Postnatal women who delivered are counselled for adapting any of 
the available forms of contraception and also the risks involved in future 
pregnancies should be explained to the patient and her partner, which is 
most important. Birth spacing for a minimum of three years should be 
advised for primigravida mothers. Puerperal sterilization is advised for 
the women who have completed their families. In women in whom PS 
could not be done, vasectomy is advised to their spouse. In the women 
who have not completed their family or in whom sterilization procedures 
could not be carried out IUCDs are inserted under strict aseptic 
precautions with infective endocarditis prophylaxis.  
  
RESULTS 
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RESULTS 
                This study was conducted in the Department of Obstetrics and 
Gynaecology, Govt.RSRM hospital, Stanley Medical College, Chennai 
for a period of ten months from January 2017 to October 2017. A total 
number of 100 pregnant women with heart disease were included in the 
study.  
TABLE 1 
OBSTETRIC CODE 
 
Frequency Percentage 
 
Primi 52 52.0% 
Multi 48 48.0% 
Total 100 100 
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      Among the 100 pregnant women with heart disease admitted to the 
hospital 52 were Primi gravida and multigravida were 48 in numbers. 
Prevalence of heart disease in our hospital is 1.29%. 
 
 
 
  
52% 
48% 
GRAVIDA 
Primi Multi
48 
 
TABLE 2 
SOCIOECONOMIC STATUS 
 
Frequency Percentage 
 
III 48 48.0% 
IV 52 52.0% 
Total 100 100 
 
In our study 48 pregnant women belongs to socio economic class 
III and 52 pregnant women comes under socio economic class IV. 
 
        Distribution of women as per socio economic status 52% in class III 
and 48% in class IV. 
48% 
52% 
SOCIO ECONOMIC STATUS 
III IV
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TABLE 3  
PREVIOUS MODE OF DELIVERY 
 
Frequency Percentage 
 
Abortion 5 10.41% 
FTND 22 45.84% 
LSCS 21 43.75% 
Total 48 100 
 
            In this study, 22 pregnant women had previous full term normal 
delivery and caesarian section was performed in 21 cases. 5 pregnant 
women admitted to the hospital with cardiac disease underwent D&C for 
abortion. Remaining 52 cases are Primi gravida 
TABLE 4 
GESTATIONAL AGE 
  Frequency Percentage 
  Ist Trimester 13 13.0% 
Preterm 4 4.0% 
Term 82 82.0% 
Postdated 1 1.0% 
Total 100 100 
 
 
Gestational age in the pregnant women at the time of admission to 
the hospital was studied: 82% of the patients belong to term gestation. 
Preterm labour 4% of the cases and first trimester abortion occurred in 
13%. 1 women with heart disease was referred to our hospital as 
postdated. 
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TABLE 5 
NYHA GRADING 
  Frequency Percentage 
  I 85 85.0% 
II 13 13.0% 
III 2 2.0% 
Total 100 100 
  
The cardiac functional status of the pregnant women with heart 
disease at the time of admission to the hospital was studied: Most of the 
patients have stable cardiac status and they fall under class I-85%. 13% of 
the pregnant women belong to NYHA class II and 2% of the cases belong 
to NYHA class III at the time of admission. 
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TABLE 6 
AGE RANGE 
  Frequency Percentage 
  Up to 20 yrs 11 11.0% 
21 - 25 yrs 43 43.0% 
26 - 30 yrs 39 39.0% 
Above 30 yrs 7 7.0% 
Total 100 100 
 
Age wise distribution among the pregnant women with heart 
disease was studied: About 43% were in the age group of 21 to 25 years, 
39% of the cases come under 26 to 30 years. There were 7% of the cases 
above 30 years. Teenage pregnancy was seen in 11% of the cases. 
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TABLE 7 
TYPE OF HEART DISEASE 
  
Frequency Percentage 
 
CHB 1 1.0% 
 
CHD 29 29.0% 
 
MVP 14 14.0% 
 
RHD 56 56.0% 
 
Total 100 100 
 
Echocardiography helps in diagnosing heart disease in pregnant 
women. About 56% of the women had rheumatic heart disease and 29% 
had congenital heart disease. Mitral valve prolapse is seen in 14% of the 
cases and is mostly an incidental finding during ECHO study. Congenital 
heart block was seen in 1case and it is belongs to type 1 CHB. 
 
1% 
29% 
14% 
56% 
TYPE OF HEART DISEASE 
CHB CHD MVP RHD
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About 27 pregnant women were found to have heart disease during 
the antenatal period, 3 cases diagnosed during the postnatal period. 
Among this postnatal cases 1 women found to have VSD with 
eisenmenger syndrome and she was started on T.digoxin, T.bosentan.  
1 women was diagnosed as having heart disease during intraoperative 
period and ECHO confirmed diagnosis in the postoperative period as 
RHD-MS. 
TABLE 8 
RHD TYPE 
Lesion Number Percentage 
Isolated MS 19 33.34% 
Isolated MR 11 19.29% 
MS/MR 10 17.54% 
MS/PHT 3 5.27% 
MS/Atrial Fibrillation 3 5.27% 
Other combined lesions 11 19.29% 
Total 57 100 
 
           Isolated rheumatic mitral stenosis was seen in 19 cases. MS with 
MR is seen in 10 cases. MS with pulmonary hypertension is seen in 3 
cases and MS with AF seen in 3 cases.  
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TABLE 9 
CHD TYPE 
Type of CHD Number Percentage 
ASD 10 34.48% 
ASD with PHT 2 6.90% 
VSD 7 24.13% 
TOF 4 13.81% 
PDA 6 20.68% 
Total 29 100 
 
In our study, commonest congenital heart disease noted was ASD. 
Along with ASD pulmonary hypertension developed in 2 cases. 7 patients 
with congenital heart disease belong to VSD in our study.  
TABLE 10 
SURGICAL CORRECTION 
 
Frequency Percentage 
 
Nonsurgical 76 76.0% 
Surgical 24 24.0% 
Total 100 100 
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TABLE 11 
SURGERIES 
In 100 cases about 23 pregnant women underwent cardiac surgery 
and 1 women diagnosed as a case of ASD is planned for ASD closure 
after delivery. Various types of surgical corrections underwent are as 
follows: 
Corrective Procedure No. of women Percentage 
Mitral valve replacement 3 13.04% 
Closed mitral commisurotomy 4 17.40% 
Double valve replacement 1 4.35% 
ASD Closure 5 21.73% 
VSD Closure 1 4.35% 
PDA ligation 5 21.73% 
TOF corrected 4 17.40% 
Total 23 100 
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TABLE 12 
MODE OF DELIVERY 
       Among 100 pregnant women 14 cases were admitted during their 
firsttrimester with complaints such as bleeding per vaginum, ultrasound 
finding of missed abortion and manual vacuum aspiration with check 
curettage is done for such cases. Among the remaining 86 cases, 
caesarian section was performed in 56 women including both elective and 
emergency procedures. Pregnant women admitted to the labour ward with 
adequate cervical dilatation and satisfactory progress of labour with 
stable cardiac status is allowed a natural course of labour. About 15 
women had outlet forceps delivery and it is mainly done to cut short the 
second stage of labour. 
 
Frequency Percentage 
 
Assisted vaginal delivery 15 17.4% 
Elective 23 26.8% 
Emergency 33 38.4% 
Labour natural 15 17.4% 
Total 86 100 
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CAESARIAN SECTION 
            Caesarian section in pregnant women with cardiac disease was 
performed mainly due to obstetric indications. Of the 86 deliveries, 23 
cases underwent elective LSCS and emergency LSCS was done in 33 
cases. 
TABLE 13  
LSCS 
Type Number Percentage 
Elective 23 41.07% 
Emergency 33 58.93% 
Total 56 100 
 
Indications for LSCS 
         In emergency caesarian section performed the most common 
indication is fetal distress followed by CPD. Severe oligohydramnios was 
seen in 2 cases and breech with long period of secondary infertility in 1 
case for which LSCS was done. 
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TABLE 14 
INDICATION FOR EMERGENCY LSCS: 
Type No. of women Percentage 
Fetal distress 13 39.40% 
CPD 8 24.24% 
Failed induction 3 9.09% 
Fetal alarm signal 3 9.09% 
Severe oligohydraminos 2 6.06% 
Failure to progress 2 6.06% 
Breech 1 3.03% 
Previous LSCS 1 3.03% 
Total 33 100 
 
Indications for elective LSCS: 
The most common indication for elective LSCS is CPD, Previous 
LSCS.  
CPD or cephalo pelvic disproportion was the common cause for 
elective Caesarean section in this study group. 
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TABLE 15 
Causes Number of women Percentage 
Previous LSCS with CPD 19 82.60% 
Breech 3 13.05% 
Previous 2 LSCS 1 4.35% 
Total 23 100 
 
TABLE 16 
TYPE OF ANESTHESIA 
Spinal anesthesia was administered to 45.7% of the cases and 
general anesthesia was given to 11.4% of cases. 22.8% of the pregnant 
women were administered combined spinal epidural. About 14 cases 
were admitted in the first trimester with missed abortion, incomplete 
abortion and IV sedation was administered to them, which also includes 1 
case of molar pregnancy.  
 
Frequency Percentage 
 
Combined epidural spinal 16 22.85% 
GA 8 11.44% 
IV sedation 14 20.0% 
Spinal 32 45.71% 
Total 70 100 
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TABLE 17 
ANESTHESIA COMPLICATIONS 
   Various types of anesthesia were administered to 70 cases and 
anesthesia complications occurred in 6 cases. 
Type of Complication Number of Cases 
Fall in SPO2 3 
Pulmonary edema 3 
Total 6 
 
TABLE 18 
POSTOPERATIVE COMPLICATIONS 
       Pregnant women with heart disease delivered should be monitored 
vigorously in the immediate postnatal period. Strict vitals monitoring, 
maintaining intake output chart, administering antibiotics, nasal oxygen 
were given. Cardiologist review should be obtained postnatally and if the 
patient was on cardiac drugs, it should be continued. 
Complications Number of Patients 
LRI 3 
Pulmonary edema 1 
Dyspnea 1 
Pulmonary embolism 1 
Total 6 
 
       In the immediate postop period, one women having MS with atrial 
fibrillation developed pulmonary embolism and expired of sudden cardio 
respiratory arrest. 
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TABLE 19 
 DURATION OF STAY IN ICU 
          Cardiac patients with NYHA grade 3 or 4, Severe MS with atrial 
fibrillation, AS, uncorrected cyanotic heart disease requires intensive 
care. Women in the postnatal period also require intensive care since they 
can develop cardiac failure. About 68% of the cases were observed for 24 
to 48 hours. 
 
Frequency Percentage 
 
< 24 hrs 11 11.0% 
24 - 48 hrs 68 68.0% 
48 - 72 hrs 6 6.0% 
> 72 hrs 15 15.0% 
Total 100 100 
 
       Patients diagnosed to have MS with pulmonary hypertension, MS 
with atrial fibrillation requires a longer period of ICU stay. 
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TABLE 20 
NEED FOR VENTILLATORY SUPPORT 
             Out of 100 pregnant women studied, 16 cases required ventilator 
care. Most of the cardiac patients were connected to elective ventilatory 
support. 5 cases of MS with PHT were put on ventilation. 2 cases 
diagnosed to have mitral stenosis with atrial fibrillation were connected to 
ventilator. Cases that were put on elective mechanical ventilation are 
mostly weaned in 24 hours. 
 
Frequency Percentage 
 
No 82 82.0% 
Yes 18 18.0% 
Total 100 100 
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TABLE 21 
NEONATAL OUTCOME 
The Pregnancy outcome in 100 patients was studied. 14 patients were 
admitted for first trimester miscarriage. Of the remaining 86 cases 
preterm birth occurred in 3.5%, Term delivery in 94.2% of the cases, 
1.2% of the baby was delivered after completion of 40 weeks of 
gestation. 
 
Frequency Percentage 
 
Border line 1 1.16% 
Post term 1 1.16% 
Preterm 3 3.49% 
Term 81 94.19% 
Total 86 100.0 
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TABLE 22 
NICU ADMISSION 
               Neonate born to pregnant mothers complicated by heart disease 
requiring NICU care was studied in detail. Out of the 86 babies born 35 
required admissions to the NICU. These babies were screened for heart 
disease by performing ECHO. In our study, the screening for the heart 
disease is negative for these babies. 
 
Frequency Percentage 
 
No 51 59.3% 
Yes 35 40.7% 
Total 86 100.0 
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TABLE 23 
REASON FOR NICU ADMISSION 
Neonates born by assisted vaginal delivery were observed in 
NICU, which includes 29 babies. 3 babies required IV antibiotics - Their 
mothers admitted with complaints of draining per vagina. 2 babies found 
to have single umbilical artery and further investigations found to be 
normal. Anomaly scan of the fetus showing mild hydroureteronephrosis 
investigated postnatlly and it is on regular follow up at pediatric OPD. 
 
 
Frequency Percentage 
 
Anamolies 3 3.0% 
IV Antibiotics 3 3.0% 
Nil 65 65.0% 
Observation 29 29.0% 
Total 100 100.0 
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TABLE 24 
BIRTH WEIGHT 
              Neonatal outcome in terms of birth weight of the babies were 
studied. Most of the babies born are with birth weight of 2.5 to 3kgs. 
69.8% of the babies come under this group. 23.3% of the babies have 
birth weight of more than 3kgs. Low birth weight was seen in 7% of the 
cases. 
 
Frequency Percentage 
 
< 2.5 kgs 6 7.0% 
2.5 - 3 kgs 60 69.7% 
> 3 kgs 20 23.3% 
Total 86 100 
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             Out of this birth, weight of 1 baby was 4kg and admitted in NICU 
evaluated for large for gestation. Baby was discharged from NICU on 6
th
 
postnatal day. 
 
 
Descriptive Statistics 
 
N Minimum Maximum Mean 
Std. 
Deviation 
Age 100 19 38 25.29 3.566 
Duration of disease 65 0.03 26.0 9.740 6.5515 
Baby weight 86 1.6 4.1 2.910 .3575 
Duration of hospital 
Stay/days 
100 5 28 14.03 5.028 
 
 
7% 
70% 
23% 
BABY WEIGHT/Kgs 
< 2.5 kgs 2.5 - 3 kgs > 3 kgs
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Statistical significance of different variables with heart disease are 
studied as follows 
TABLE 25 
AGERANGE * TYPE OF HEART DISEASE 
The distribution of RHD is seen maximum in age range of 21 to 30 
years. Teenage pregnancy with RHD is seen in 5 women. 
  
Type of heart disease 
Total 
  
CHB CHD MVP RHD 
Age range 
Up to 20 yrs 0 2 4 5 11 
21 - 25 yrs 0 14 6 23 43 
26 - 30 yrs 1 11 4 23 39 
Above 30 yrs 0 2 0 5 7 
Total 1 29 14 56 100 
 
 
P value is 0.521, which means there is no statistical difference 
between age range and heart disease. 
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TABLE 26 
GRAVIDA * TYPE OF HEART DISEASE 
  
Type of heart disease 
Total 
  
CHB CHD MVP RHD 
Gravida 
Primi 0 17 6 29 52 
Multi 1 12 8 27 48 
Total 1 29 14 56 100 
 
 
RHD was seen in 29 primi and 27 multipara. Among CHD 17 
cases are seen in primi and 12 cases among multipara. The P value 
derived is 0.560, which means there is no statistical significance between 
gravida and heart disease. 
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TABLE 27 
SURGERY * TYPE OF HEART DISEASE 
  
Type of heart disease 
Total 
  
CHB CHD MVP RHD 
Surgery 
Non surgical 1 13 14 48 76 
Surgical 0 16 0 8 24 
Total 1 29 14 56 100 
 
 
 
Majority of patients with CHD underwent surgical procedure prior 
to conception.55.7% of patients had corrective surgery. Among RHD 
patients,16.6% underwent surgery prior to pregnancy. The comparison 
between Surgery and Heart disease types shows that there is statistical 
significance with P value < 0.001. 
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TABLE 28 
TYPE OF ANESTHESIA * TYPE OF HEART DISEASE 
  
Type of heart disease 
Total 
  
CHB CHD MVP RHD 
Type of 
anaesthesia 
CES 0 0 0 16 16 
GA 1 1 0 6 8 
IV sedation 0 3 1 6 10 
Normal 0 14 6 14 34 
Spinal 0 11 7 14 32 
Total 1 29 14 56 100 
 
 
The comparison between anesthesia and heart diseases shows that 
there is statistical significance with P value < 0.001 
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TABLE 29 
MEDICAL TREATMENT * TYPE OF HEART DISEASE 
  
Type of heart disease 
Total 
  
CHB CHD MVP RHD 
Medical treatment 
No 1 26 10 20 57 
Yes 0 3 4 36 43 
Total 1 29 14 56 100 
 
 
             Major pregnant women with RHD are under cardiac 
drugs.64.28% of patients with RHD are getting cardiac medications. In 
CHD 10.34% of patients are under cardiac drugs.28.57% of MVP 
patients are under drugs. The comparison between medical treatment and 
heart diseases shows that there is statistical significance with  
P value <0.000 
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TABLE 30 
NEED FOR VENTILATORY SUPPORT * TYPE OF HEART 
DISEASE 
  
Type of heart disease 
Total 
  
CHB CHD MVP RHD 
Need for  
ventilatory support 
No 1 28 14 39 82 
Yes 0 1 0 17 18 
Total 1 29 14 56 100 
 
 
  Ventilatory support is mostly needed for RHD.30.35%of patients 
with RHD required ventilation. Most patients were put on elective 
mechanical ventilation. 3.4% of women with CHD requires ventilator 
support.  The P value is 0.004 hence it is denotes there is statistical 
difference between the type of heart disease and need for ventilator 
support. 
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TABLE 31 
ECHO FINDINGS: 
  
Type of heart disease 
Total 
  
CHB CHD MVP RHD 
ECHO 
Abnormal 1 22 13 54 90 
Normal 0 7 1 2 10 
Total 1 29 14 56 100 
 
ECHO findings are categorized in to normal or abnormal based on 
EF, PHTN, valve area, residual shunt lesion etc. Among RHD 96.42% 
have abnormal findings in ECHO.78.56%of women with CHD are found 
to have abnormal ECHO findings. The comparison between Echo and 
Heart disease types shows that there is statistical significance with  
P = 0.026  
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DISCUSSION 
Heart disease complicates about 1 to 3% of pregnancies. It causes 
major impact on maternal and fetal outcome. This study reflects the 
maternal and fetal outcomes in women with heart disease treated in our 
hospital. The prevalence of heart disease among the pregnant women 
attending this center was 1.29%. In various studies prevalence varies 
from 0.3- 3.5%
40.
 This being a referral center the prevalence rate may not 
reflect that of the general population. The study population was 100 
pregnant women. Of these, MVA with check curettage was done in  
12 cases and MTP/TAT was done in 3 cases. The prevalence of heart 
disease among pregnant women was as follows in various studies: 
Name of the study Year Prevalence (%) 
Mahesh K
15 
1995-2006 1.52 
Suman P
16 
2012 4.3 
Nagamani G
17 
2013-14 1.2 
Ashwini M
18 
2004-13 0.4 
Indira I
22 
2006-07 0.43 
Our study 2016-17 1.29 
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ANTENATAL CARE 
All pregnant women with heart disease were booked case. All 
antenatal women were given iron and folic acid tablets during all three 
trimesters. Tamil Nadu is well known for the high standards of antenatal 
care. 33% (n=33) of the women were diagnosed to have heart disease for 
first time during the current pregnancy. The commonest age group 
distribution was 21 – 25 (n=43, 43%). Of the 100 women enrolled in the 
study, 11% (n=11) were below 20 years of age. Major portion of women 
included in this study are primi gravida, 52%. 
HEART DISEASE 
The commonest type of heart disease is RHD (n=56, 56%) which is 
similar to other Indian studies
37, 41, 42, 43.  
Among these, mitral stenosis was 
the most common type. Isolated MS was noted in 33.34% of the cases 
(n=19). This study similar to several other Indian studies
37, 42.  
In western 
studies, congenital heart disease was the commonest type. About 8 
women with RHD had underwent surgical treatment, valve replacement 
was done in 3 cases, combined valve replacement performed in 1 case, 
CMC was done in 4 cases. Severity of the stenosis was correlated with 
higher NYHA functional class.   
77 
 
Congenital heart disease was seen in 29 cases (29%), commonest 
type being atrial septal defect, which includes 10 cases. 2 cases of ASD 
with pulmonary hypertension, were also included in our study. Ashwini 
M & Gayatridevi J conducted a study and found that 40% had undergone 
surgical correction of which one fourth were done during pregnancy
19. 
In 
our study one women diagnosed to have ASD was planned for surgical 
closure after delivery. TOF corrected was seen in 4 cases.VSD with 
Eisenmenger’s syndrome was seen in one case which was diagnosed in 
the immediate postnatal period.  Her intra partum and postpartum period 
were uneventful. She was started on T.digoxin and T.bosentan.   
In pregnancy mitral valve prolapse is mostly an incidental finding. 
Widespread use of the echo has detected many asymptomatic cases. In 
our study MVP seen in 14 cases. Pregnant outcome in patients with 
isolated MVP is usually uneventful. If MVP associated with significant 
regurgitation, they should be monitored closely for complications like 
arrhythmia, thrombosis. In our study MVP with mild regurgitation seen in 
3 cases. All women with MVP had a good maternal and fetal outcome. 
 Congenital heart block – Type 1 was seen in 1 women. Repeat 
LSCS was done in that case and her intra operative and postoperative 
period were uneventful. Maternal death was seen in 1 case – severe MS 
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with atrial fibrillation. Patient was on anticoagulants, T.Penicillin. Repeat 
LSCS was done. Intraoperative period was uneventful. In the immediate 
postop period patient developed pulmonary embolism and died of sudden 
cardio respiratory arrest. 
NYHA CLASS 
Majority of the women included in our study were admitted with 
NYHA Class I (n=85, 85%) and Class II (n=13, 13%). About 2% of the 
women belong to NYHA class III
8, 42
. Cardiac status based on NYHA 
functional classification was an independent predictor of cardiac event in 
a Canadian multicenter study by Sameul C, Siu etal
30
. 
 Out of 86 women, delivered normal labour was seen in 15 women 
(17.4%). Caesarian section both elective and emergency was performed 
in 56 cases (65.2%). Most common indications for LSCS are fetal distress 
and CPD. The second stage was cut short by use of forceps in 15 cases 
(17.4%). Assisted vaginal delivery to cut short the second stage has been 
recommended by various other studies
1, 44, 45.
 . Forceps delivery was 
performed mainly to relieve maternal exhaustion. Preterm labour was 
seen in 3 cases, reason being hypoxia in heart disease may cause cervical 
softening and onset of labour.  
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CARDIAC COMPLICATIONS 
Six women developed intraoperative cardiac complication. 3 
women developed intraoperative pulmonary edema and 3 cases had 
intraoperative fall in spo2. Postop complications were noted in 6 cases. 
Pulmonary edema seen in 1 case LRI developed in 3 cases, dyspnea in 1 
case and pulmonary embolism in another case. Pulmonary edema was the 
common complication in many studies
15, 22, 30.
 Ventilatory support was 
required in 18 cases, most of the cardiac patients were put on elective 
mechanical ventilation and weaned in 24 hours. Patients who developed 
LRI, pulmonary edema were also opted for ventilator support. Antibiotic 
prophylaxis is administered to the cardiac mothers and we had no case of 
endocarditis.  
NEONATAL COMPLICATIONS  
Most of the babies born have birth weight of 2.5 to 3kg, 60 babies 
(69.8%) are included in this group. Low birth weight was seen in 6 babies 
(7%). 29 babies admitted in NICU. Maternal cardiac disease was 
associated with an increased risk of neonatal complications
30, 46.
 In 
cardiac mothers, there is increased incidence of Low birth weight 
babies
46, 47, 48.
 Placental insufficiency usage of drugs like beta blockers are 
associated with increased incidence of IUGR/Low birth weight babies. 
80 
 
Mahesh Koregol et al conducted a study and found that the rate of NICU 
admission was 30.1%
15.
 Surgne et al proposed that the perinatal outcome 
in women with RHD was good and comparable to mothers in general 
population. The inheritance of congenital heart disease in newborn was 
studied by shime et al and found that the incidence was 13%.  No heart 
disease was detected in babies born to cardiac mothers in our study. 
 29 babies delivered by forceps were observed in NICU. 3 babies 
were admitted for getting IV antibiotics. 1 baby having birth weight more 
than 4kg admitted for LGA evaluation. Another baby evaluated for single 
umbilical artery, another one for renal anomaly and found to be normal.   
          There is strong association between maternal cyanosis and fetal 
growth.  There is inverse relationship between the maternal oxygen 
saturation and birth weight of babies. Utero placental insufficiency due to 
left heart obstruction leads to preterm delivery, IUGR, IUD. Placental 
insufficiency leads to hypoxic acidosis, which in turn affects the fetal 
cardiac contractility and cardiac output. This may lead to preterm 
delivery. With improved antenatal care, adequate management of 
comorbidities and increased institutional deliveries there is a declining 
trend in perinatal morbidity and mortality.   
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Early diagnosis, preconceptional counseling, health education, 
routine and regular antenatal checkup, identifying and correcting the 
factors aggravating heart failure, regular cardiac follow up, strict 
adherence to cardiac drugs, institutional delivery may help in improving 
outcome for both mother and the babies.  
 
COMPARISION WITH OTHER STUDIES 
The various important results calculated from this study are 
compared with that of other studies in the following table: 
Parameter 
Our 
study 
Mahesh 
Suman 
P 
Nagamani Ashwini Indira 
Reference  (15) (16) (17) (18) (22) 
Prevalence 1.08 1.52 4.3 1.2 0.4 0.43 
% Gravida I,  52.0 I,  52.72 I,  57 II, 45 I,  56.7 I,  42 
% RHD 56.0 86.44 70.10 60 66.7 80 
% MS 61.40 62.75 60.30 54 89.74 91.67 
% CHD 29.0 13.56 9.28 40 33.3 18.33 
% Neonatal 
deaths 
0 2.9 0 5.0 1.67 0 
% Maternal 
deaths 
1.0 3.6 3.09 5.0 3.3 6.6 
 
 
SUMMARY 
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SUMMARY 
1.  The study was conducted in the Department of Obstetrics and 
Gynaecology, GOVT RSRM Hospital, Stanely Medical College, 
during January 2017 to October 2017. 
2.  100 cases of heart disease complicating pregnancy were studied. 
3.  The prevalence of heart disease among the women who delivered 
here was 1.29%. 
4.  Of 100 women, 86 were admitted for safe confinement and 14 
cases were admitted for first trimester abortion.  
5.  33% of the women were diagnosed to have heart disease for first 
time in pregnancy. Of these , RHD was seen in 19% of cases, MVP 
seen in 6%,CHD in 7% cases, CHB in 1%. 
6.  Teenage pregnancy with heart disease was found in 11 cases.  
7.  Rheumatic heart disease is seen in 56% of the cases and congenital 
heart disease in 29% of the women.  
8.  98 women (98%) had NYHA class I or II symptoms. 
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9.  Isolated MS was seen in 19 cases (33.34%). 
10.  ASD was the commonest congenital heart disease, seen in 10 
 (34.48%) women. ASD with PHT is seen in 2 cases. 
11.  23 women had undergone cardiac corrective surgeries. Of these 
surgery for congenital heart disease was done in 15 patients,  
8 patients underwent surgery for RHD. 
12.  56 women (65.20%) delivered by Cesarean section and 30 (34.8%) 
by vaginal route. 
13.  Intraoperative complications and postoperative complications were 
seen in 6 cases. 
 14.  The number of NICU admissions was 35. 6 babies were preterm. 
There were no neonatal deaths. 
15.  Ventilatory support was given to 18 cases (18%) 
16.  One maternal death (1%) was noted during our study. Pulmonary 
embolism with cardio respiratory arrest in the postop period found 
to be the cause. 
 
CONCLUSION 
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CONCLUSION 
Heart disease is the most common non obstetric cause of maternal 
morbidity and mortality. It also has a major impact on neonatal outcome. 
Favorable outcome is noted in women with NYHA class I and II, 
avoidance of factors precipitating heart failure like anemia, infections, 
arrhythmias, regular cardiac follow up, strict adherence to cardiac 
medications. Pregnancy should be avoided in women with severe type of 
heart disease and in such cases; surgical procedures should be performed 
in the pre pregnancy period itself. Pregnant women with heart disease are 
advised to have regular and frequent antenatal visits. During pregnancy, 
corrective procedures if required should be done in the second trimester 
but it carries significant fetal risk. Cardiac drugs taken prior to pregnancy 
should be reviewed by the cardiologist. Delivery should preferably 
conduct in a tertiary care centre with multi-disciplinary approach. Fetal 
ECHO performed around 20 weeks of gestation to find out inherited heart 
diseases in newborn.  Universal access to obstetric and cardiac care and 
use of standard treatment protocol will definitely improve the outcome in 
women with cardiac disease.                        
 
ANNEXURES 
 
PROFORMA 
NAME: 
AGE:   
IP NO: 
SOCIOECONOMIC CLASS: 
RELIGION: 
OCCUPATION: 
DOA: 
D.O.DELIVERY: 
DOD:                                              
ADDRESS & CONTACT NO:                                                                       
OBSTETRIC CODE: 
PRESENTING COMPLAINTS:   
MENSTRUAL HISTORY:                 
MARITAL HISTORY:       
OBSTETRIC HISTORY:                                       
CONTRACEPTION HISTORY: 
PAST MEDICAL HISTORY: 
HISTORY OF CARDIAC DISEASES AND DURATION: 
HISTORY OF ANY CARDIAC SURGERIES: 
HISTORY OF INTAKE OF CARDIAC DRUGS: 
HISTORY OF 
DIABETES/HYPERTENSION/PULMONARYTUBERCULOSIS/BRO
NCHIAL ASTHMA/EPILEPSY/ENDOCRINE DISORDER: 
 
ANY OTHER MEDICATIONS:  
FAMILY HISTORY:   
GENERAL EXAMINATION:                                   
VITALS: TEMPERATURE 
                PULSE RATE 
                RESPIRATORY RATE 
                BLOOD PRESSURE            
CARDIOVASCULAR SYSTEM: 
NYHA GRADE 
RESPIRATORY SYSTEM: 
ABDOMINAL EXAMINATION: 
PER VAGINAL EXAMINATION: 
INVESTIGATIONS:  
 
URINE ALBUMIN 
SUGAR 
HB% 
BLOOD GROUPING/RH TYPING 
HIV (WITH CONSENT) 
VDRL 
BLOOD SUGAR, UREA 
ECG 
ECHO 
CARDIOLOGY OPINION 
FETAL DOPLER 
PREGNANCY OUTCOME: 
SPONTANEOUS ABORTION / THERAPEUTIC ABORTION / 
PRETERM DELIVERY / TERM DELIVERY 
MODE OF DELIVERY: LSCS /NORMAL VAGINAL DELIVERY 
/ASSISTED DELIVERY 
FETAL OUTCOME  
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1 Mrs. Malathy 29 9th IV G2P1L1 LSCS 36 Referred as heart disease II RHD, Severe PHT 17Yrs 12Yrs
T.Penicillin 1bd
T.Lasix
2 Mrs. Shabina Begum 25 10th III G2P1L1 FTND 36 Referred as Oligohydramnios I CHD 13Yrs 12Yrs -
3 Mrs. Shanthi 32 12th III G2A1 Ab 38 Galactorrhea I RHD 24th week - -
4 Mrs.Priya 20 12th IV Primi - 39 Safe confinment I MVP 28th week -
T.Penicillin 1bd
T.Lasix
5 Mrs.Dowlath 20 8th IV Primi - 39 Lowerabdomen pain I MVP 18Yrs 2Yrs -
6 Mrs.Renuka 24 Bcom III G2P1L1 LSCS 38 Lowerabdomen pain I RHD 15Yrs 9Yrs
T.Penicillin 1bd
7 Mrs.Saibunisha 29 8th III G2P1L1 LSCS 38 Safe confinment I MVP 22Yrs 7Yrs T.Propranolol 1bd
8 Mrs.Sabana 25 6th IV G2P1L1 FTND 39 Referred as heart disease III RHD 22Yrs 3Yrs
T.Penicillin 1bd
T.Lasix
9 Mrs.Shameem 28 10th IV G3P2L2 LSCS 38 Safe confinment I CHD 16Yrs 12Yrs -
10 Mrs.Deepa 24 8th III G4P3L3A1 FTND 8 Missed Abortion I CHD 20Yrs 4Yrs -
11 Mrs.Karthika 27 12th III Primi - 39 Safe confinment II RHD with PHT 14Yrs 13Yrs Inj.Heparin
12 Mrs.Nalini 26 BA III Primi - 40 Safe confinment I RHD 12Yrs 14Yrs -
13 Mrs.Madhavi 29 6th IV G3P2L2 FTND 39 Safe confinment I CHD with Mild PHT 15Yrs 14Yrs -
14 Mrs.Krithika 24 BA III Primi - 39 Safe confinment I RHD 38th week - -
15 Mrs.Selvi 30 6th IV G4P2L2A1 FTND 10 Pt wants MTP I RHD 10 days -
T.Lasix 1/2 bd
16 Mrs.Sangeetha 24 BSC III Primi - 8 Missed Abortion I RHD 13Yrs 11Yrs Anticoagulants
17 Mrs.Lathiswari 24 12th IV Primi - 39 Safe confinment I CHD 10Yrs 14Yrs -
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18 Mrs.Devi 21 5th IV G2P1L1 FTND 39 Lower abdomen pain I
CHD with 
Eisenmengers PN -
T.Digoxin 1/2 od
T.Bosentan 1bd
19 Mrs.Sharmila 19 12th IV Primi - 40 Safe confinment I RHD 38th week - -
20 Mrs.Sarala 22 10th IV Primi - 40 Swelling of both legs I RHD 38th week -
21 Mrs.Annabakiyam 31 2nd IV G2P1L1 LSCS 38 Safe confinment I CHD 5Yrs 26Yrs -
22 Mrs. Saranya 23 BSc III G2P1L1 LSCS 38 Referred as heart disease I RHD 20Yrs 3Yrs -
23 Mrs. Chithra 25 8th III G2P1L1 LSCS 38 Safe confinment I MVP 22Yrs 3Yrs -
24 Mrs. Aktharbegum 26 10th III Primi - 40 Referred as heart disease I CHD 3Yrs 23Yrs
25 Mrs. Sowbagya 19 10th IV Primi - 38 Referred as heart disease I MVP 37th week - -
26 Mrs. Srimathy 24 12th III G2P1L1 FTND 39 Referred as heart disease I MVP 5Yrs 19Yrs -
27 Mrs. Sugantha 31 BA III G2P1L1 LSCS 38 Lower abdomen pain II RHD 24Yrs 5Yrs
T.Penicillin 1bd
T.Acitrom 2mg
28 Mrs. Fathima Banu 21 10th IV Primi - 39 Lower abdomen pain I CHD 5Yrs 16Yrs -
29 Mrs.Seetha 24 8th IV Primi - 38 Lower abdomen pain I MVP 30th week - -
30 Mrs.Durga 20 10th III Primi - 10 Bleeding pervagina I CHD 8Yrs 12Yrs -
31 Mrs. Lakshmi 30 6th IV G2P1L1 LSCS 39 Referred as heart disease II RHD 28Yrs 2Yrs
32 Mrs.Joycemarry 30 12th III G2P1L1 FTND 40 Referred as heart disease I CHD 10Yrs 20Yrs -
33 Mrs.Sasikala 24 10th IV Primi - 41 Referred as postdated I RHD Admission -
T.Lasix 1/2 bd
34 Mrs. Radha 22 12th IV G2P1L1 FTND 38 Referred as MRO I RHD 18Yrs 4Yrs
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35 Mrs.subbu 28 6th IV G3P2L2 FTND 38 Referred as heart disease I RHD 24Yrs 4Yrs
36 Mrs.Barkathbanu 21 11th III Primi - 39 Missed Abortion I CHD 8Yrs 13Yrs -
37 Mrs. Raghini 24 12th IV G2P1L1 LSCS 38 Safe confinment I RHD 22Yrs 2Yrs
38 Mrs. Revathi 26 10th III Primi - 38 Referred as short primi I CHD 10Yrs 16Yrs -
39 Mrs. Yogalakshmi 22 12th III Primi - 39 Lower abdomen pain I RHD Intra op -
T.Lasix 1/2 bd
40 Mrs. Savitha 26 10th III G2P1L1 LSCS 38 Referred as heart disease III RHD Severe MS, AF 23Yrs 3Yrs
T.Penicillin 1bd
T.Lasix 1/2 bd
41 Mrs. Saibunisha 29 8th IV G2P1L1 LSCS 38 Safe confinment I MVP 26Yrs 3Yrs T.Propranolol 1/2bd
42 Mrs. Shruthi 32 10th III G2P1L1 LSCS 38 Safe confinment I RHD 28Yrs 4Yrs -
43 Mrs.Gnanavalli 20 12th IV Primi - 39 Lower abdomen pain I RHD 20Yrs 2Wks
T.Penicillin 1bd
T.Lasix 1/2 bd
44 Mrs.Bavithra 20 12th III G2A1 Ab 39 Referred as PROM I RHD 20Yrs 3Wks -
45 Mrs. Priyadharsini 29 BA III Primi - 8 Referred as heart disease I RHD 20Yrs 9Yrs
46 Mrs. Deepika 27 Bcom III Primi - 38 Referred as PROM I RHD 24th week -
T.Lasix 1 bd
47 Mrs. Anthony Marry 22 8th IV Primi - 40 Referred as heart disease I RHD 32th week - -
48 Mrs. Ammukutty 31 12th IV Primi - 39 Safe confinment II CHD 20th week - -
49 Mrs. Gowthami 26 8th IV G3P1L1A1 LSCS 38 Safe confinment I RHD 23Yrs 3Yrs
50 Mrs. Agalya 28 12th IV Primi - 40 Safe confinment I CHD 5Yrs 23Yrs -
51 Mrs. Gowri 24 12th IV Primi - 38 Safe confinment I MVP 24th week -
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52 Mrs. Dahira 22 10th III Primi - 39 Referred as heart disease I CHD 32th week - -
53 Mrs. Shifana 24 12th IV Primi - 38 Referred as heart disease I CHD 10Yrs 14Yrs -
54 Mrs. Kalpana 35 BA III Primi - 38 Referred as heart disease II RHD, MS, AF 38th week -
T.Penicillin 1bd
Digoxin 1/2 od
55 Mrs. Sowmya 22 12th III G2P1L1 FTND 39 Safe confinment I MVP 38th week - -
56 Mrs. Sangeetha 20 10th III G2P1L1 FTND 38 Safe confinment I RHD Childhood -
57 Mrs. Elakkiya 26 12th III Primi - 10 Referred as heart disease I RHD 9th week -
T.Penicillin 1bd
T.Lasix 1/2 bd
58 Mrs. Ramani 28 10th Iv G2P1L1 LSCS 38 Lower abdomen pain I RHD 24Yrs 4Yrs
59 Mrs. Madhavi 24 10th Iv Primi - 39 Referred as heart disease I RHD 9Yrs 15Yrs
T.Penicillin 1bd
T.Lasix 1/2 bd
60 Mrs. Divya 22 12th Iv Primi - 10 Referred as heart disease I RHD 8thweek - -
61 Mrs. Faritha 21 8th Iv Primi - 38 Referred as MRO I CHD 8Yrs 13Yrs -
62 Mrs.Devika 24 10th III G2P1L1 LSCS 38 Safe confinment I MVP 28th week - -
63 Mrs.Marry 28 10th IV G2A1 Ab 38 Referred as precious pregnancy I RHD 38thweek - -
64 Mrs.Mala 28 8th IV Primi - 39 Safe confinment I CHD 10Yrs 18Yrs -
65 Mrs. Annakili 24 6th IV Primi - 8 Referred as heart disease I RHD 6th week - -
66 Mrs. Jayanthi 24 10th III Primi - 38 Referred as heart disease I RHD 13Yrs 11Yrs
67 Mrs. Ananthi 38 10th III G2P1L1 FTND 40 Referred as heart disease in labour I RHD 40th week - -
68 Mrs. Vijaya 24 12th III Primi - 39 Referred as heart disease I CHD 38thweek - -
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69 Mrs. Nanthini 26 BA III Primi - 40 Referred as heart disease I RHD 13Yrs 13Yrs
T.Penicillin 1bd
T.Lasix 1/2 bd
70 Mrs. Thangamani 28 4th IV G3P2L2 LSCS 38 Safe confinment I RHD 22Yrs 6Yrs
T.Penicillin 1bd
T.Lasix 1bd
71 Mrs. Janaki 24 BA III Primi - 37 Safe confinment II RHD 20Yrs 4Yrs
T.Penicillin 1bd
T.Lasix 1bd
72 Mrs. Jaya 20 8th IV Primi - 10 Referred as heart disease I CHD 7Yrs 13Yrs -
73 Mrs.Gowri 24 10th III G2A1 Ab 37 Referred as heart disease I RHD 36th week -
T.Penicillin 1bd
T.Lasix 1/2 bd
74 Mrs. Deiva 28 Bcom III Primi - 38 Referred as heart disease II RHD 25Yrs 3Yrs
T.Penicillin 1tds
T.Acitrom 1od
75 Mrs. Sakeera 20 8th IV Primi - 39 Lower abdomen pain I MVP 8Yrs 16Yrs -
76 Mrs. Harini 25 BSC III Primi - 39 Lower abdomen pain II RHD 21Yrs 4Yrs
T.Penicillin 1bd
T.Lasix 1 bd
77 Mrs. Sandiya 28 12th III G2A1 Ab 39 Safe confinment I RHD 32nd week - -
78 Mrs. Sulaika 25 12th IV Primi - 35 Referred as MRO I CHD 7Yrs 18Yrs -
79 Mrs.Baby 26 8th IV G2P1L1 FTND 38 Safe confinment I CHD 8Yrs 18Yrs -
80 Mrs. Mohana 27 12th III G2P1L1 FTND 9 Referred as missed abortion I MVP 23Yrs 4Yrs -
81 Mrs. Saritha 24 12th IV Primi - 38 Safe confinment I CHD 10Yrs 14Yrs -
82 Mrs. Vanitha 22 12th III Primi - 38 Safe confinment I RHD 36th week - -
83 Mrs. Esther 28 8th IV G2P1L1 LSCS 38 Referred as heart disease II CHD 8Yrs 20Yrs -
84 Mrs. Geetha 26 10th III G2P1L1 FTND 40 Referred as MRO I RHD 20Yrs 6Yrs
85 Mrs. Nithya 24 12th IV Primi - 39 Referred as CPD I RHD IMM.PP -
T.Penicillin 1bd
T.Lasix 1/2 bd
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86 Mrs. Valli 28 8th IV G3P2L2 FTND 9 Referred as incomplete abortion I RHD 26Yrs 2Yrs -
87 Mrs. Kalaiarasi 26 8th III G2P1L1 FTND 39 Lower abdomen pain II CHD IMM.PP -
88 Mrs. Anitha 28 12th IV G2P1L1 FTND 39 Lower abdomen pain I RHD 24Yrs 4Yrs -
89 Mrs. Manimegalai 24 BA III Primi - 39 Complaints of difficulty in breathing II RHD 39th week -
T.Penicillin 1bd
T.Lasix 1bd
90 Mrs. Kannagi 28 9th IV G3P2L2 FTND 10 Wants MTP I RHD 23Yrs 5Yrs -
91 Mrs. Rani 25 12th III Primi - 39 Safe confinment I RHD 36th week -
92 Mrs. Durga 26 BA III Primi - 39 Referred as heart disease I RHD 23Yrs 3Yrs -
93 Mrs. Jyothi 30 8th IV G3P2L2 FTND 35 Referred as MRO I MVP 23Yrs 7Yrs -
94 Mrs. Kavitha 24 12th III G2P1L1 FTND 39 Lower abdomen pain I CHD 8Yrs 16Yrs -
95 Mrs. Uma 26 8th IV G2P1L1 LSCS 38 Safe confinment II
RHD - Severe MS, 
Severe PHT 12Yrs 14Yrs
T.Penicillin 1bd
T.Lasix 1/2bd
96 Mrs. Ranjani 22 12th IV Primi - 9 Referred as missed abortion I RHD 20Yrs 2Yrs -
97 Mrs. Gayathri 24 Bsc III Primi - 38 Safe confinment I CHD 12Yrs 12Yrs -
98 Mrs.Shankari 26 10th IV G2P1L1 LSCS 38 Safe confinment I CHD 12Yrs 14Yrs -
99 Mrs. Bharathi 20 10th IV Primi - 40 Safe confinment I RHD 36th week - -
100 Mrs. Karthika 26 8th IV G4P2L2A1 LSCS 38 Safe confinment I CHB 38th week - -
1 Mrs. Malathy Closed Mitral Commisurotomy
MVA-0.8 cm2
TRPG-91 mm of Hg T EL.LSCS with ST PrevLSCS, CPD CES
2 Mrs. Shabina Begum Double ligation of PDA Normal PT Vaginal delivery - -
3 Mrs. Shanthi - Normal T EM.LSCS with CuT Fetal alarm signal Spinal
4 Mrs.Priya - Normal T EM.LSCS with CuT PROM, Fetal distress Spinal
5 Mrs.Dowlath - Mitral Valve Prolapse - AML T EM.LSCS with CuT MSAF, Fetal distress Spinal
6 Mrs.Renuka Closed Mitral Commisurotomy Mild MS /Mild MR T EL.LSCS with ST PrevLSCS, CPD CES
7 Mrs.Saibunisha - TrivialMR T EL.LSCS with ST PrevLSCS, CPD Spinal
8 Mrs.Sabana -
MVA-1.2 cm2
No LA/LV clot T LN with EPI - -
9 Mrs.Shameem TOF operated 12yrs back Normal T EL.LSCS with ST PrevLSCS, CPD Spinal
10 Mrs.Deepa - Normal Ab MVA with ST - IV S
11 Mrs.Karthika Mitral valve replacement Severe MR T AVD - -
12 Mrs.Nalini - Mild MS /Mild MR T EM.LSCS with CuT Failed induction GA
13 Mrs.Madhavi
Planned for ASD closure after 
delivery Normal T LN with EPI - -
14 Mrs.Krithika - Normal T EM.LSCS with CuT CPD in labour CES
15 Mrs.Selvi - MildMS Ab MVA with ST - IV S
16 Mrs.Sangeetha Mitral valve replacement MR Ab MVA with check curettage - IV S
17 Mrs.Lathiswari - Normal T EM.LSCS with CuT CPD in labour Spinal
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18 Mrs.Devi -
Large subaortic VSD,
Bicuspid aortic valve and Mild to T AVD - -
19 Mrs.Sharmila - TrivialMR T AVD - -
20 Mrs.Sarala - RHD-AML,PML thickened, MildMR T EM.LSCS with CuT MSAF, Fetal distress Spinal
21 Mrs.Annabakiyam PDA closure done at 5yrs No obvious residual shunt T EL.LSCS PrevLSCS, CPD Spinal
22 Mrs. Saranya - Lvsystolic function Bicuspid Aortic valve T EL.LSCS PrevLSCS, CPD CES
23 Mrs. Chithra -
MVP-AML  VPC normal
LV Systolic function T EL.LSCS PrevLSCS, Breech Spinal
24 Mrs. Aktharbegum -
Mild TR
LV Systolic function  no DA/DV clots T AVD - -
25 Mrs. Sowbagya -
TrivialMR
MVP-Anterior mitral leaflet T EM.LSCS with CuT PROM, Fetal distress Spinal
26 Mrs. Srimathy -
MVP
MR Trivial T LN with EPI - -
27 Mrs. Sugantha
Mitral valve replacement
Tricuspid valve replacement
MV-Prosthetic valve
Severe TR T EM.LSCS with CuT PrevLSCS, CPD in labour CES
28 Mrs. Fathima Banu ASD operated  Normal LV Systolic function T EM.LSCS with CuT PROM, Fetal distress Spinal
29 Mrs.Seetha - MVP - AML Normal LV systolic function T LN with EPI - -
30 Mrs.Durga - Normal Ab MVA with check curettage - IV S
31 Mrs. Lakshmi - MVA - 1.5cm2 EF 65% T EL.LSCS with ST PrevLSCS, CPD Spinal
32 Mrs.Joycemarry ASD operated at 10yrs of age Normal T AVD - -
33 Mrs.Sasikala -
MS, MVA 1.2cm2  Normal LV systolic 
function PoT EM.LSCS with CuT Failed induction CES
34 Mrs. Radha - RHD-AML thickened, MildMR T LN with EPI - -
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35 Mrs.subbu -
Mild MR MVA 1.5 cm2 Normal LV 
Systolic function T LN with EPI - -
36 Mrs.Barkathbanu PDA ligation done No obvious residual shunt Ab MVA with check curettage - IV S
37 Mrs. Raghini - MildMS, EF 65% T EL.LSCS with ST PrevLSCS, CPD GA
38 Mrs. Revathi TOF operated Normal, EF 65% T EM.LSCS with CuT CPD in labour Spinal
39 Mrs. Yogalakshmi - MS, MVA 1.2cm2 , EF 56% T EM.LSCS with CuT Failiure to progress Spinal
40 Mrs. Savitha - Mitral Valve area 0.9 cm2 T EM.LSCS PrevLSCS, CPD in Labour GA
41 Mrs. Saibunisha - Trivial MR T EL.LSCS with ST PrevLSCS, CPD Spinal
42 Mrs. Shruthi - Trivial TR T EL.LSCS with ST PrevLSCS, CPD Spinal
43 Mrs.Gnanavalli - Moderate MR - Degenerating T AVD - -
44 Mrs.Bavithra - Mild MR with MVP T EM.LSCS with CuT Severe Oligohydramnias, PROM Spinal
45 Mrs. Priyadharsini - MR with Mild TR Ab MVA with check curettage - IV S
46 Mrs. Deepika - Mild MR EF 60% T EM.LSCS with CuT PROM, Fetal distress Spinal
47 Mrs. Anthony Marry - Mild TR T EM.LSCS with CuT CPD in labour Spinal
48 Mrs. Ammukutty -
ASD/Large left to right shunt Moderate 
PHT T EM.LSCS with CuT MSAF, Fetal distress GA
49 Mrs. Gowthami - Mild MR T EL.LSCS with ST CPD Major Spinal
50 Mrs. Agalya PDA closure done at 5yrs Normal LV systolic function T EM.LSCS with CuT Failiure to progress Spinal
51 Mrs. Gowri - MVP - AML, Trivial MR T AVD - -
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52 Mrs. Dahira - Small PDA, IAS/IVS intact T EM.LSCS with CuT CPD in labour Spinal
53 Mrs. Shifana -
Small PDA/ Small ASD
Left to Right shunt T LN with EPI - -
54 Mrs. Kalpana -
AML/PML thickened, MS Moderate MR 
Mild, MVA 1.5 cm2 T EM.LSCS with CuT PROM, Fetal distress GA
55 Mrs. Sowmya - MR Trivial, MVP - AML T LN with EPI - -
56 Mrs. Sangeetha - Trivial MR/Mild TR T AVD - -
57 Mrs. Elakkiya - MS Mild, MVA 1.8 cm2, EF 65% Ab MVA with check curettage - IV S
58 Mrs. Ramani - MS Mild MR Mild, MVA 1.8 cm2 T EM.LSCS with ST CPD in labour GA
59 Mrs. Madhavi - AML dome plus severe MS MVA 0.8cm2 T Elective LSCS done CPD CES
60 Mrs. Divya - MR Mild MOP MVA with check curettage - IV S
61 Mrs. Faritha ASD operated at 9yrs of age
No residual shunt
Normal LV systolic function T EM.LSCS with CuT MRO, Fetal distress Spinal
62 Mrs.Devika - MVP - AML, Trivial MR T EL.LSCS with ST PrevLSCS, Breech Spinal
63 Mrs.Marry -
Trivial MR/Trivial TR
Normal LV systolic function T EM.LSCS with CuT Fetal alarm signal Spinal
64 Mrs.Mala VSD operated at 11yrs of age
No residual shunt
Normal LV systolic function T AVD - -
65 Mrs. Annakili - MR Mild Ab MVA with check curettage - IV S
66 Mrs. Jayanthi Closed Mitral Commisurotomy MS, MVA 1.2 cm2, EF 60% T Elective LSCS done Breech CES
67 Mrs. Ananthi - Mild TR, Normal LV systolic function T EM.LSCS with ST
Long period of Secondary infertility, 
Breech Spinal
68 Mrs. Vijaya -
ASD, Defect 1.2 cm2, Normal LV systolic 
function T AVD - -
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69 Mrs. Nanthini -
MS Moderate, MR Mild, No evidence of 
PHT T EM.LSCS with CuT Severe Oligohydramnias, Fetal distress CES
70 Mrs. Thangamani -
Mild MS /Mild MR, MVA 1.5 cm2, EF 
65% T EL.LSCS with ST Prev 2 LSCS, CPD CES
71 Mrs. Janaki Closed Mitral Commisurotomy MS Severe MVA 0.8 cm2, Mild PHT T EM.LSCS with CuT PROM, Fetal distress GA
72 Mrs. Jaya TOF operated at 8yrs of age
No residual shunt
Normal LV systolic function Ab MVA with check curettage - IV S
73 Mrs.Gowri - MR Moderate, No evidence of PHT T EM.LSCS with CuT MRO, fetal distress CES
74 Mrs. Deiva Mitral valve replacement done
Mitral valve - Prosthetic valve
Normal ventricular function T EL.LSCS with ST Prev LSCS, CPD CES
75 Mrs. Sakeera - MVP - AML, Trivial MR T LN with EPI - -
76 Mrs. Harini - MVA - 1 cm2 , No LA/LV clot, No PHT T AVD - -
77 Mrs. Sandiya -
MR Trivial/TR Trivial
LV systolic function T Elective LSCS done Breech Spinal
78 Mrs. Sulaika -
VSD, Defect 0.8 cm2, Normal LV systolic 
function PT LN with EPI - -
79 Mrs.Baby ASD operated at 9yrs of age
No residual shunt
Normal LV systolic function T LN with EPI - -
80 Mrs. Mohana - MVP - AML Ab MVA with check curettage - IV S
81 Mrs. Saritha - Normal LV systolic function T AVD - -
82 Mrs. Vanitha - Trivial MR T LN with EPI - -
83 Mrs. Esther PDA closure done at 8yrs of age
No residual shunt
Normal LV systolic function T EL.LSCS with ST Prev LSCS, CPD Spinal
84 Mrs. Geetha - MS Mild Normal LV systolic function T Emergency LSCS MRO, Fetal distress Spinal
85 Mrs. Nithya -
MS Moderate, MR Mild, Normal LV 
systolic function T Emergency LSCS CPD in labour CES
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86 Mrs. Valli - TR Trivial Ab MVA with check curettage - IV S
87 Mrs. Kalaiarasi -
Large subaortic VSD,
Bicuspid aortic valve T AVD - -
88 Mrs. Anitha - Trivial MR T LN with EPI - -
89 Mrs. Manimegalai - MS Moderate, MR Mild, EF 65% T Elective LSCS done Primi, CPD Major CES
90 Mrs. Kannagi - MR Trivial Ab MTP with TAT - -
91 Mrs. Rani - MS Mild, Normal LV systolic function T AVD - -
92 Mrs. Durga - MR Trivial/TR Trivial T EM.LSCS with CuT MSAF, Fetal distress Spinal
93 Mrs. Jyothi - MVP anterior mitral leaflet PT LN with EPI - -
94 Mrs. Kavitha ASD operated at 10yrs of age ASD, No residual shunt T LN with EPI - -
95 Mrs. Uma -
MVA 0.8cm2, Severe MS, Severe PHT, 
No MR/AS/AR T EL.LSCS with ST Prev LSCS, CPD CES
96 Mrs. Ranjani - MR Mild Ab MVA with check curettage - IV S
97 Mrs. Gayathri TOF operated at 13yrs of age No residual shunt T EM.LSCS with CuT Fetal alarm signal Spinal
98 Mrs.Shankari - VSD, Normal LV systolic function T EL.LSCS with ST Pre LSCS, CPD Spinal
99 Mrs. Bharathi - MS Mild /MR Mild T EM.LSCS with CuT Failed induction CES
100 Mrs. Karthika - Normal LV systolic function T EL.LSCS with ST Prev LSCS, CPD GA
1 Mrs. Malathy - - 4 21 Yes T 2.8 - - N
2 Mrs. Shabina Begum - - 2 14 - PT 1.6 Yes LBW N
3 Mrs. Shanthi - - 2 14 - T 3 Yes Obs N
4 Mrs.Priya - - 1 14 - T 2.9 Yes Obs N
5 Mrs.Dowlath - - 1 14 - T 3 Yes - N
6 Mrs.Renuka - - 4 21 Yes T 3 - - N
7 Mrs.Saibunisha - - 1 14 - T 2.8 - - N
8 Mrs.Sabana - - 4 21 - T 2.9 - - N
9 Mrs.Shameem - - 1 10 - T 2.5 - - N
10 Mrs.Deepa - - 1 10 - - - - - N
11 Mrs.Karthika - - 3 21 Yes T 3 Obs - N
12 Mrs.Nalini - - 2 14 - T 2.2 Yes LBW N
13 Mrs.Madhavi - - 1 7 - T 3.5 - - N
14 Mrs.Krithika - - 1 14 - T 2.8 - - N
15 Mrs.Selvi - - 1 10 - - - - - N
16 Mrs.Sangeetha - - 1 10 - - - - - N
17 Mrs.Lathiswari - - 1 14 - T 2.8 - - N
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18 Mrs.Devi - - 7 21 - T 3 Yes Obs N
19 Mrs.Sharmila - - 1 10 - T 3.2 - - N
20 Mrs.Sarala - - 1 14 - T 3.2 Obs - N
21 Mrs.Annabakiyam - - 1 14 - T 3.1 - - N
22 Mrs. Saranya - - 1 14 - T 2.9 yes Single UA N
23 Mrs. Chithra - - 1 12 - T 3.6 - - N
24 Mrs. Aktharbegum - - 2 14 - T 3.5 Yes Obs N
25 Mrs. Sowbagya - - 1 12 - T 3.1 Yes Obs N
26 Mrs. Srimathy - - 0.5 10 - T 2.1 - - N
27 Mrs. Sugantha Intraop pulmonary edema - 3 21 Yes T 2.8 - - N
28 Mrs. Fathima Banu - - 1 14 Yes T 2.8 Yes Obs N
29 Mrs.Seetha - - 0.5 10 - T 2.6 - - N
30 Mrs.Durga - - 0.5 7 - - - - - N
31 Mrs. Lakshmi - - 1 14 - T 3 - - N
32 Mrs.Joycemarry - - 0.5 7 - T 3.4 - Obs N
33 Mrs.Sasikala - - 2 21 Yes PoT 3.2 Yes Obs N
34 Mrs. Radha - - 0.5 7 - T 2.8 - - N
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35 Mrs.subbu - - 0.5 10 - T 3.4 - - N
36 Mrs.Barkathbanu - - 1 7 - - - - - N
37 Mrs. Raghini - - 1 14 - T 2.6 - - N
38 Mrs. Revathi - - 1 14 - T 3.1 - - N
39 Mrs. Yogalakshmi Intraop fall in saturation
Pulmonary edema in immediate post 
op period 3 28 Yes T 2.6 - - N
40 Mrs. Savitha Intraop pulmonary edema
Patient died of sudden cardio 
respiratory arrest 4 28 Yes T 2.6 - - N
41 Mrs. Saibunisha - - 1 12 - T 2.8 - - N
42 Mrs. Shruthi - - 1 12 - T 3 - - N
43 Mrs.Gnanavalli - - 2 14 - T 2.6 Yes Obs N
44 Mrs.Bavithra - - 1 14 - T 2.3 Yes SGA N
45 Mrs. Priyadharsini - - 1 10 - - - - - N
46 Mrs. Deepika Intraop fall in saturation - 4 21 Yes T 3 Yes Obs N
47 Mrs. Anthony Marry - - 2 12 - T 3.2 - - N
48 Mrs. Ammukutty - - 3 21 - T 3 Yes Obs N
49 Mrs. Gowthami - - 1 14 - T 2.9 - - N
50 Mrs. Agalya - - 1 14 - T 2.8 - - N
51 Mrs. Gowri - - 1 14 - T 3 Yes Obs N
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52 Mrs. Dahira - - 2 12 - T 3.1 - - N
53 Mrs. Shifana - - 0.5 12 - T 2.5 - - N
54 Mrs. Kalpana - - 3 21 Yes T 2.8 Yes Antibiotics N
55 Mrs. Sowmya - - 0.5 10 - T 2.5 - - N
56 Mrs. Sangeetha - - 0.5 10 - T 3 Yes Obs N
57 Mrs. Elakkiya - - 1 7 - - - - - N
58 Mrs. Ramani - - 2 14 - T 2.8 - - N
59 Mrs. Madhavi - - 4 28 Yes T 3.4 - - N
60 Mrs. Divya - - 1 10 - - - - - N
61 Mrs. Faritha - - 2 12 - T 3 Yes Obs N
62 Mrs.Devika - - 1 14 - T 2.8 - - N
63 Mrs.Marry - - 1 12 - T 3 - - N
64 Mrs.Mala - - 2 14 - T 2.8 Yes Obs N
65 Mrs. Annakili - - 1 5 - - - - - N
66 Mrs. Jayanthi - - 2 14 - T 3 - - N
67 Mrs. Ananthi - - 1 12 - T 4.1 Yes  LGA N
68 Mrs. Vijaya - - 1 10 - T 2.8 Yes Obs N
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69 Mrs. Nanthini - - 3 21 Yes T 3.1 Yes  RA N
70 Mrs. Thangamani Intraop fall in saturation - 5 21 Yes T 3 - - N
71 Mrs. Janaki - - 5 21 Yes T 2.8 Yes Obs N
72 Mrs. Jaya - - 2 12 - - - - - N
73 Mrs.Gowri - - 2 14 - T 3 Yes Antibiotics N
74 Mrs. Deiva - - 4 21 Yes T 3 - - N
75 Mrs. Sakeera - - 1 12 - T 2.7 - - N
76 Mrs. Harini - - 4 28 Yes T 2.9 Yes Obs N
77 Mrs. Sandiya - - 1 12 - T 2.9 - - N
78 Mrs. Sulaika - - 1 14 - PT 2 Yes LBW N
79 Mrs.Baby - - 1 10 - T 3.5 - - N
80 Mrs. Mohana - - 1 10 - - - - - N
81 Mrs. Saritha - - 1 10 - T 3 Yes Obs N
82 Mrs. Vanitha - - 2 10 - T 2.8 Yes Obs N
83 Mrs. Esther - - 2 12 - T 2.9 - - N
84 Mrs. Geetha - - 1 14 - T 3 Yes Obs N
85 Mrs. Nithya - - 2 14 - T 3.2 - - N
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86 Mrs. Valli - - 0.5 8 - - - - - N
87 Mrs. Kalaiarasi - Dyspnea 4 18 - T 3 Yes Obs N
88 Mrs. Anitha - - 0.5 14 - T 2.6 - - N
89 Mrs. Manimegalai - LRI 4 21 Yes T 3.4 - - N
90 Mrs. Kannagi - - 1 7 - - - - - N
91 Mrs. Rani - - 2 12 - T 2.9 Yes Obs N
92 Mrs. Durga - LRI 2 14 - T 3 Yes Obs N
93 Mrs. Jyothi - - 1 9 - PT 2.2 Yes Antibiotics N
94 Mrs. Kavitha - - 1 12 - T 2.8 - - N
95 Mrs. Uma Intraop pulmonary edema - 5 21 Yes T 2.8 - - N
96 Mrs. Ranjani - - 1 7 - - - - - N
97 Mrs. Gayathri - LRI 4 21 - T 3.4 Yes Obs N
98 Mrs.Shankari - - 2 14 - T 3 - - N
99 Mrs. Bharathi - - 2 14 - T 2.8 - - N
100 Mrs. Karthika - - 2 14 - T 3 - - N
CODING FOR MASTER CHART 
CODE : DESCRIPTION 
EDU : Education 
SES : Socioeconomic status 
Obs : Observation 
GA : General anesthesia 
PREG OC : Pregnancy outcome 
MOD : Mode of delivery 
INDI : Indication 
AC : Anesthetic complication 
VS : Ventilatory support 
OC : Outcome 
DUR : Duration 
T : Term 
PT : Preterm 
PoT : Post term 
EM.LSCS : Emergency LSCS 
EL.LSCS : Elective LSCS 
N : Normal 
LN with Epi : Labour natural with episiotomy 
AVD : Assisted vaginal delivery 
Ab : Abortion 
MOP : Molar pregnancy 
LBW : Low birth weight 
UA : Umbilical artery 
CES : Combined epidural spinal 
IV S : Intravenous sedation 
LGA : Large for gestation 
 
ABBREVATIONS 
APLA : Antiphospho lipid antibody syndrome. 
AR  : Aortic regurgitation 
AS  : Aortic stenosis  
ASD  :  Atrial septal defect 
CES  : Combined epidural spinal 
CHB  : Congenital heart block 
CHD  :  Congenital heart disease 
CMC  : Closed mitral commissurotomy 
CPD  : Cephalo pelvic disproportion 
ECG  : Electro cardiogram 
ECHO : Echocardiography 
EF  : Ejection fraction 
GA  : Gestational age 
GDM  :  Gestational diabetes mellitus 
IE  : Infective endocarditis 
IUGR  :  Intra uterine growth retardation 
IUCD  :  Intrauterine contraceptive device 
IVC  : Inferior vena cava 
LGA  : Large for gestation 
LMWH : Lowmolecular weight heparin 
LSCS  : Lower segment ceasarian section 
LV  : Left ventricle 
MR  : Mitral regurgitation 
MS  : Mitral stenosis 
MTP  : Medical termination of pregnancy 
MVP  : Mitral valve prolapse 
NICU  : Neonatal intensive care unit 
NYHA : New York heart association 
OAC  : Oral anti coagulant 
OPD  : Outpatient department 
PDA  : Patent ductus arteriosus 
PHT  : Pulmonary hypertension 
PPCM : Peripartum cardiomyopathy 
PPH  : Postpartum haemorrhage 
PPHTN : Primary pulmonary hypertension 
RHD  : Rheumatic heart disease 
SABE : Subacute bacterial endocarditis 
ST  : Sterilisation 
TAT  : Transabdominal tubectomy 
TOF  : Tetralogy of Fallot 
UFH  : Unfractionated heparin 
VSD  : Ventricular septal defect 
WHO  : World health organisation 
 
CONSENT FORM 
I  agree to participate in the study entitled MATERNAL AND 
FETAL OUTCOME IN PREGNANCIES WITH MATERNAL 
CARDIAC DISEASES.  
I confirm that I have been told about this study in my mother 
tongue and have had the opportunity to clarify my doubts.  
I understand that my participation  is voluntary and I may refuse to 
participate at any time without  giving any reasons and without affecting 
my benefits.  
I agree not to restrict the use  of any data or results that arise from 
this study.  
   
 
Name of the participant :  
Sign / Thumb print:  
Name of the investigator: Dr.R.RAMIPRIYA  
Sign of Investigator :  
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